Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship, Urologic Oncology, Johns Hopkins University 1997 - 1998
  • Assistant Chief of Service, Urology, Johns Hopkins University 1997
  • Chief Resident, Urology, Johns Hopkins University 1996 - 1997
  • Resident, Urology, Johns Hopkins University 1993 - 1996
  • Assistant Resident in General Surgery, Surgery, Johns Hopkins University 1992 - 1993
  • Intern in General Surgery, Surgery, Johns Hopkins University 1991 - 1992
  • M.D., University of Chicago 1991
• 

  Duke Appointment History

  • Associate Professor of Surgery, Surgery, Urology, Surgery 2009 - 2011
  • Associate Professor of Surgery, Surgery, Urology, Surgery 2003 - 2009
  • Assistant Professor of Surgery, Surgery, Urology, Surgery 2001 - 2003
  • Assistant Clinical Professor of Surgery, Surgery, Urology, Surgery 1998 - 2001
• Recognition
• 

  In the News

  • JAN 5, 2015

    WRAL

    New imaging detects more prostate tumors
• Research
• 

  Selected Grants

  • Image guided targeted biopsy of clinically significant prostate cancer with acoustic radiation force awarded by National Institutes of Health 2010 - 2022
  • Early Detection of Clinically Significant Prostate Cancer using Ultrasonic Acoustic Radiation Force Impulse (ARFI) Imaging awarded by United States Army Medical Research Acquisition Activity 2016 - 2019
  • Prospective registry to optimize clinical care (DUCIMAS) awarded by Myriad Genetics, Inc. 2016 - 2019
  • MIP proSPECT-AS awarded by Molecular Insight Pharmaceuticals, Inc. 2016 - 2019
  • A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in a awarded by AngioDynamics 2014 - 2018
  • Prostate Cancer Assessment and Treatment Guidance Via Integrated 3D ARFI Elasticity Imaging and Multi-Parametric MRI awarded by Kitware Inc. 2015 - 2016
  • Evaluation of Sexual Function after Primary and Salvage Prostate Cryoablation for Localized Prostate Cancer awarded by Josiah Charles Trent Memorial Foundation 2010 - 2011
  • Trent Foundation Grant awarded by Josiah Charles Trent Memorial Foundation 2006 - 2009
  • Psychobiology of male sexual dysfunction following treatment of prostate cancer awarded by Josiah Charles Trent Memorial Foundation 2002 - 2003
• Publications & Artistic Works
• 

  Selected Publications

  • Books

    • Polascik, T. J. Preface, 2013. https://doi.org/10.1007/978-1-62703-182-0.
       Full Text

  • Academic Articles

    • Aminsharifi, Alireza, Ariel Schulman, Lauren E. Howard, Kae Jack Tay, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, et al. “Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy..” Cancer, May 1, 2019. https://doi.org/10.1002/cncr.32168.
       Full Text  Link to Item
    • Berger, Miles, Deborah Oyeyemi, Mobolaji O. Olurinde, Heather E. Whitson, Kent J. Weinhold, Marty G. Woldorff, Lewis A. Lipsitz, et al. “The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction..” Journal of the American Geriatrics Society 67, no. 4 (April 2019): 794–98. https://doi.org/10.1111/jgs.15770.
       Full Text  Open Access Copy
    • Tay, Kae Jack, Mahul B. Amin, Sangeet Ghai, Rafael E. Jimenez, James G. Kench, Laurence Klotz, Rodolfo Montironi, et al. “Surveillance after prostate focal therapy..” World Journal of Urology 37, no. 3 (March 2019): 397–407. https://doi.org/10.1007/s00345-018-2363-y.
       Full Text
    • Aminsharifi, Alireza, Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Thomas J. Polascik, and Stephen J. Freedland. “Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database..” Clin Genitourin Cancer 17, no. 1 (February 2019): e140–49. https://doi.org/10.1016/j.clgc.2018.09.020.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Rajan T. Gupta, Efrat Tsivian, Sitharthan Sekar, Christina Sze, and Thomas J. Polascik. “Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - An alternative template for prostate fusion biopsy..” European Journal of Radiology 110 (January 2019): 7–13. https://doi.org/10.1016/j.ejrad.2018.11.006.
       Full Text
    • Luijtelaar, A. van, B. M. Greenwood, H. U. Ahmed, A. B. Barqawi, E. Barret, J. G. R. Bomers, M. A. Brausi, et al. “Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.” World Journal of Urology, January 1, 2019. https://doi.org/10.1007/s00345-019-02636-7.
       Full Text
    • Polascik, Thomas J. “The use of multiparametric MRI in diagnosis and active surveillance of prostate cancer..” Clinical Advances in Hematology & Oncology : H&O 16, no. 12 (December 2018): 798–99.
    • Aminsharifi, Alireza, Ariel Schulman, John Anderson, Laura Fish, Kevin Oeffinger, Kevin Shah, Christina Sze, Kae J. Tay, Efrat Tsivian, and Thomas J. Polascik. “Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record..” Urologic Oncology 36, no. 11 (November 2018): 502.e1-502.e6. https://doi.org/10.1016/j.urolonc.2018.07.016.
       Full Text
    • Aminsharifi, Alireza, Jean de la Rosette, and Thomas J. Polascik. “Focal therapy of prostate and kidney cancer..” Current Opinion in Urology 28, no. 6 (November 2018): 491–92. https://doi.org/10.1097/mou.0000000000000552.
       Full Text
    • Aminsharifi, Alireza, Rajan T. Gupta, Jiaoti Huang, and Thomas J. Polascik. “Three-dimensional localization and targeting of prostate cancer foci with imaging and histopathologic correlation: establishing a multidisciplinary team for quality improvement..” Current Opinion in Urology 28, no. 6 (November 2018): 506–11. https://doi.org/10.1097/mou.0000000000000554.
       Full Text
    • Sanchez-Salas, Rafael, Jean de la Rosette, Thomas J. Polascik, Arie Carneiro, Arjun Sivaraman, Xavier Cathelineau, and Jochen Walz. “Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients..” European Urology 74, no. 5 (November 2018): 537–39. https://doi.org/10.1016/j.eururo.2018.04.018.
       Full Text
    • Aminsharifi, Alireza, Lauren Howard, Yuan Wu, Amanda De Hoedt, Charlotte Bailey, Stephen J. Freedland, and Thomas J. Polascik. “Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer When the Prostate Specific Antigen is in the Diagnostic Gray Zone: Defining the Optimum Cutoff Point Stratified by Race and Body Mass Index..” J Urol 200, no. 4 (October 2018): 758–66. https://doi.org/10.1016/j.juro.2018.05.016.
       Full Text  Link to Item
    • Aminsharifi, Alireza, Thomas J. Polascik, Ariel Schulman, Kae Jack Tay, Ghalib Jibara, Christina Sze, Efrat Tsivian, Ahmed Elshafei, and J Stephen Jones. “Predictors of Rectourethral Fistula Formation After Primary Whole-Gland Cryoablation for Prostate Cancer: Results from the Cryo On-Line Database Registry..” Journal of Endourology 32, no. 9 (September 2018): 791–96. https://doi.org/10.1089/end.2018.0357.
       Full Text
    • Aminsharifi, Alireza, and Thomas J. Polascik. “Re: Prevalence and Prognosis of Low-volume, Oligorecurrent, Hormone-sensitive Prostate Cancer Amenable to Lesion Ablative Therapy.” European Urology 74, no. 2 (August 2018): 234–35. https://doi.org/10.1016/j.eururo.2018.01.022.
       Full Text
    • Duvnjak, Petar, Ariel A. Schulman, Jamie N. Holtz, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making..” The Urologic Clinics of North America 45, no. 3 (August 2018): 455–66. https://doi.org/10.1016/j.ucl.2018.03.010.
       Full Text
    • Tsivian, Matvey, Michael R. Abern, Efrat Tsivian, Christina Sze, Ghalib Jibara, Edward N. Rampersaud, and Thomas J. Polascik. “Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma..” Urologic Oncology 36, no. 8 (August 2018): 362.e1-362.e7. https://doi.org/10.1016/j.urolonc.2018.04.014.
       Full Text
    • Aminsharifi, Alireza, and Thomas J. Polascik. “Editorial Comment.” The Journal of Urology 199, no. 6 (June 2018): 1508–9. https://doi.org/10.1016/j.juro.2017.12.078.
       Full Text
    • Aminsharifi, Alireza, and Thomas J. Polascik. “Re: Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9–10 Prostate Cancer.” European Urology, June 2018. https://doi.org/10.1016/j.eururo.2018.05.031.
       Full Text
    • Punnen, S., S. J. Freedland, T. J. Polascik, S. Loeb, M. C. Risk, S. Savage, S. C. Mathur, E. Uchio, Y. Dong, and J. L. Silberstein. “A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men.” Journal of Urology 199, no. 6 (June 1, 2018): 1459–63. https://doi.org/10.1016/j.juro.2017.11.113.
       Full Text
    • Elshafei, Ahmed, Kae Jack Tay, Onder Kara, Ercan Malkoc, Yaw Nyame, Hans Arora, Asmaa Hatem, et al. “Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the Prostate..” Clinical Genitourinary Cancer 16, no. 2 (April 2018): e477–82. https://doi.org/10.1016/j.clgc.2017.10.009.
       Full Text
    • Duvnjak, Petar, Ariel A. Schulman, Jamie N. Holtz, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making..” Radiologic Clinics of North America 56, no. 2 (March 2018): 239–50. https://doi.org/10.1016/j.rcl.2017.10.007.
       Full Text
    • Holtz, Jamie N., Rachel Kloss Silverman, Kae Jack Tay, Jill T. Browning, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?.” Abdominal Radiology (New York) 43, no. 3 (March 2018): 702–12. https://doi.org/10.1007/s00261-017-1255-8.
       Full Text
    • Baust, John M., Yoed Rabin, Thomas J. Polascik, Kimberly L. Santucci, Kristi K. Snyder, Robert G. Van Buskirk, and John G. Baust. “Defeating Cancers' Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer's Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome..” Technology in Cancer Research & Treatment 17 (January 2018). https://doi.org/10.1177/1533033818762207.
       Full Text
    • Patel, Malhar P., Ariel Schulman, Kevin P. Shah, John B. Anderson, and Thomas J. Polascik. “Engaging the primary care community to encourage appropriate prostate cancer screening..” Therapeutic Advances in Urology 10, no. 1 (January 2018): 11–16. https://doi.org/10.1177/1756287217735799.
       Full Text
    • Schulman, Ariel A., Lauren E. Howard, Kae Jack Tay, Efrat Tsivian, Christina Sze, Christopher L. Amling, William J. Aronson, et al. “Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system..” Cancer 123, no. 21 (November 2017): 4122–29. https://doi.org/10.1002/cncr.30844.
       Full Text
    • Tay, K. J., M. J. Scheltema, H. U. Ahmed, E. Barret, J. A. Coleman, J. Dominguez-Escrig, S. Ghai, et al. “Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project..” Prostate Cancer and Prostatic Diseases 20, no. 3 (September 2017): 294–99. https://doi.org/10.1038/pcan.2017.8.
       Full Text
    • Tay, K. J., R. T. Gupta, J. Holtz, R. K. Silverman, E. Tsivian, A. Schulman, J. W. Moul, and T. J. Polascik. “Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance?.” Prostate Cancer and Prostatic Diseases 20, no. 3 (September 2017): 323–27. https://doi.org/10.1038/pcan.2017.20.
       Full Text
    • Tay, Kae Jack, Ariel A. Schulman, Christina Sze, Efrat Tsivian, and Thomas J. Polascik. “New advances in focal therapy for early stage prostate cancer..” Expert Review of Anticancer Therapy 17, no. 8 (August 2017): 737–43. https://doi.org/10.1080/14737140.2017.1345630.
       Full Text
    • Schulman, Ariel A., Christina Sze, Efrat Tsivian, Rajan T. Gupta, Judd W. Moul, and Thomas J. Polascik. “The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer..” Current Urology Reports 18, no. 7 (July 2017). https://doi.org/10.1007/s11934-017-0699-2.
       Full Text
    • Schulman, Ariel A., and Thomas J. Polascik. “Most of patients with localized prostate cancer will be treated in the future? | Opinion: No..” International Braz J Urol : Official Journal of the Brazilian Society of Urology 43, no. 4 (July 2017): 584–87. https://doi.org/10.1590/S1677-5538.IBJU.2017.04.03.
       Full Text
    • Tsivian, Efrat, Matvey Tsivian, Kae Jack Tay, Thomas Longo, Ziv Zukerman, Giuseppe Martorana, Riccardo Schiavina, Eugenio Brunocilla, and Thomas J. Polascik. “Body mass index and the clinicopathological characteristics of clinically localized renal masses-An international retrospective review..” Urologic Oncology 35, no. 7 (July 2017): 459.e1-459.e5. https://doi.org/10.1016/j.urolonc.2017.02.004.
       Full Text
    • Tay, Kae Jack, Thomas James Polascik, Ahmed Elshafei, Efrat Tsivian, and J Stephen Jones. “Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data..” Journal of Endourology 31, no. 6 (June 2017): 564–71. https://doi.org/10.1089/end.2016.0830.
       Full Text
    • Nyame, Yaw A., Ahmed Elshafei, Daniel J. Greene, Hans C. Arora, Robert W. Given, Kae Jack Tay, Thomas J. Polascik, et al. “Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation..” Journal of Endourology 31, no. 5 (May 2017): 497–501. https://doi.org/10.1089/end.2016.0715.
       Full Text
    • Scheltema, M. J., K. J. Tay, A. W. Postema, D. M. de Bruin, J. Feller, J. J. Futterer, A. K. George, et al. “Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project..” World Journal of Urology 35, no. 5 (May 2017): 695–701. https://doi.org/10.1007/s00345-016-1932-1.
       Full Text
    • Schulman, Ariel A., Kae Jack Tay, Cary N. Robertson, and Thomas J. Polascik. “High-intensity focused ultrasound for focal therapy: reality or pitfall?.” Current Opinion in Urology 27, no. 2 (March 2017): 138–48. https://doi.org/10.1097/mou.0000000000000372.
       Full Text
    • Schulman, Ariel A., Kae Jack Tay, and Thomas J. Polascik. “Expanding thermal ablation to the 'intermediate-sized' renal mass: clinical utility in T1b tumors..” Translational Andrology and Urology 6, no. 1 (February 2017): 127–30. https://doi.org/10.21037/tau.2017.01.08.
       Full Text
    • Tsivian, Matvey, Rajan T. Gupta, Efrat Tsivian, Peter Qi, Melissa H. Mendez, Michael R. Abern, Kae Jack Tay, and Thomas J. Polascik. “Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology..” International Journal of Urology : Official Journal of the Japanese Urological Association 24, no. 2 (February 2017): 137–43. https://doi.org/10.1111/iju.13251.
       Full Text
    • Valerio, Massimo, Yannick Cerantola, Scott E. Eggener, Herbert Lepor, Thomas J. Polascik, Arnauld Villers, and Mark Emberton. “New and Established Technology in Focal Ablation of the Prostate: A Systematic Review..” European Urology 71, no. 1 (January 2017): 17–34. https://doi.org/10.1016/j.eururo.2016.08.044.
       Full Text
    • Holtz, Jamie N., Kae Jack Tay, Thomas J. Polascik, and Rajan T. Gupta. “Integration of multiparametric MRI into active surveillance of prostate cancer..” Future Oncology (London, England) 12, no. 21 (November 2016): 2513–29. https://doi.org/10.2217/fon-2016-0142.
       Full Text
    • Postema, A. W., T. M. De Reijke, O. Ukimura, W. Van den Bos, A. R. Azzouzi, E. Barret, D. Baumunk, et al. “Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project..” World Journal of Urology 34, no. 10 (October 2016): 1373–82. https://doi.org/10.1007/s00345-016-1782-x.
       Full Text
    • Tay, Kae Jack, Arnauld Villers, and Thomas J. Polascik. “Targeted Anterior Gland Focal Therapy-a Novel Treatment Option for a Better Defined Disease..” Current Urology Reports 17, no. 10 (October 2016). https://doi.org/10.1007/s11934-016-0628-9.
       Full Text
    • Polascik, Thomas J., and Kae Jack Tay. “Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer EDITORIAL COMMENT.” Journal of Urology 196, no. 3 (September 2016): 889–889. https://doi.org/10.1016/j.juro.2016.02.3001.
       Full Text  Link to Item
    • Ehieli, Eric I., Lauren E. Howard, Terri G. Monk, Michael N. Ferrandino, Thomas J. Polascik, Philip J. Walther, and Stephen J. Freedland. “Effect of positive end-expiratory pressure on blood loss during retropubic and robot-assisted laparoscopic radical prostatectomy..” International Journal of Urology : Official Journal of the Japanese Urological Association 23, no. 8 (August 2016): 674–78. https://doi.org/10.1111/iju.13125.
       Full Text
    • Tay, Kae Jack, Rajan T. Gupta, Alison F. Brown, Rachel K. Silverman, and Thomas J. Polascik. “Defining the Incremental Utility of Prostate Multiparametric Magnetic Resonance Imaging at Standard and Specialized Read in Predicting Extracapsular Extension of Prostate Cancer..” European Urology 70, no. 2 (August 2016): 211–13. https://doi.org/10.1016/j.eururo.2015.10.041.
       Full Text
    • Gupta, Rajan T., Alison Flanagan Brown, Rachel Kloss Silverman, Kae Jack Tay, John F. Madden, Daniel J. George, and Thomas J. Polascik. “Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?.” Ajr. American Journal of Roentgenology 207, no. 1 (July 2016): 87–95. https://doi.org/10.2214/ajr.15.15878.
       Full Text
    • Tay, K. J., and T. J. Polascik. “Focal Cryotherapy for Localized Prostate Cancer..” Archivos Espanoles De Urologia 69, no. 6 (July 2016): 317–26.
    • Kovac, Evan, Ahmed ElShafei, Kae Jack Tay, Melissa Mendez, Thomas J. Polascik, and J Stephen Jones. “Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen..” Journal of Endourology 30, no. 6 (June 2016): 624–31. https://doi.org/10.1089/end.2015.0719.
       Full Text
    • Palmeri, Mark L., Tyler J. Glass, Zachary A. Miller, Stephen J. Rosenzweig, Andrew Buck, Thomas J. Polascik, Rajan T. Gupta, Alison F. Brown, John Madden, and Kathryn R. Nightingale. “Identifying Clinically Significant Prostate Cancers using 3-D In Vivo Acoustic Radiation Force Impulse Imaging with Whole-Mount Histology Validation..” Ultrasound in Medicine & Biology 42, no. 6 (June 2016): 1251–62. https://doi.org/10.1016/j.ultrasmedbio.2016.01.004.
       Full Text
    • Tay, Kae Jack, Rajan T. Gupta, Ardeshir R. Rastinehad, Efrat Tsivian, Stephen J. Freedland, Judd W. Moul, and Thomas J. Polascik. “Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls..” Expert Review of Anticancer Therapy 16, no. 3 (January 2016): 303–11. https://doi.org/10.1586/14737140.2016.1131155.
       Full Text
    • Tay, Kae Jack, Thomas J. Polascik, Ahmed Elshafei, Michael L. Cher, Robert W. Given, Vladimir Mouraviev, Ashley E. Ross, and J Stephen Jones. “Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry..” Journal of Endourology 30, no. 1 (January 2016): 43–48. https://doi.org/10.1089/end.2015.0403.
       Full Text
    • Zargar, Homayoun, Thomas D. Atwell, Jeffrey A. Cadeddu, Jean J. de la Rosette, Gunther Janetschek, Jihad H. Kaouk, Surena F. Matin, Thomas J. Polascik, Kamran Zargar-Shoshtari, and R Houston Thompson. “Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results..” European Urology 69, no. 1 (January 2016): 116–28. https://doi.org/10.1016/j.eururo.2015.03.027.
       Full Text
    • Mendez, Melissa H., Niccolo Maria Passoni, Julio Pow-Sang, J Stephen Jones, and Thomas J. Polascik. “Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population..” Journal of Endourology 29, no. 10 (October 2015): 1193–98. https://doi.org/10.1089/end.2014.0881.
       Full Text
    • Muller, B. G., W. van den Bos, M. Brausi, J. J. Fütterer, S. Ghai, P. A. Pinto, I. V. Popeneciu, et al. “Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project..” World Journal of Urology 33, no. 10 (October 2015): 1503–9. https://doi.org/10.1007/s00345-014-1475-2.
       Full Text
    • Elshafei, Ahmed, Evan Kovac, Nivedita Dhar, David Levy, Thomas Polascik, Vladimir Mouraviev, Changhong Yu, and J Stephen Jones. “A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate..” The Prostate 75, no. 13 (September 2015): 1447–53. https://doi.org/10.1002/pros.23030.
       Full Text
    • Gupta, Rajan T., Christopher R. Kauffman, Kirema Garcia-Reyes, Mark L. Palmeri, John F. Madden, Thomas J. Polascik, and Andrew B. Rosenkrantz. “Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer..” Ajr. American Journal of Roentgenology 205, no. 2 (August 2015): 331–36. https://doi.org/10.2214/AJR.14.14221.
       Full Text
    • Baust, J. G., J. C. Bischof, S. Jiang-Hughes, T. J. Polascik, D. B. Rukstalis, A. A. Gage, and J. M. Baust. “Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue..” Prostate Cancer and Prostatic Diseases 18, no. 2 (June 2015): 87–95. https://doi.org/10.1038/pcan.2014.54.
       Full Text
    • Mendez, Melissa H., Daniel Y. Joh, Rajan Gupta, and Thomas J. Polascik. “Current trends and new frontiers in focal therapy for localized prostate cancer..” Current Urology Reports 16, no. 6 (June 2015). https://doi.org/10.1007/s11934-015-0513-y.
       Full Text
    • Tay, Kae Jack, Melissa Mendez, Judd W. Moul, and Thomas J. Polascik. “Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?.” Current Opinion in Urology 25, no. 3 (May 2015): 185–90. https://doi.org/10.1097/mou.0000000000000168.
       Full Text
    • Azrad, M., R. T. Vollmer, J. Madden, T. J. Polascik, D. C. Snyder, M. T. Ruffin, J. W. Moul, D. Brenner, X. He, and W. Demark-Wahnefried. “Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial..” Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission 90, no. 3 (April 2015): 184–89. https://doi.org/10.3109/10520295.2014.976840.
       Full Text
    • Donaldson, Ian A., Roberto Alonzi, Dean Barratt, Eric Barret, Viktor Berge, Simon Bott, David Bottomley, et al. “Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting..” European Urology 67, no. 4 (April 2015): 771–77. https://doi.org/10.1016/j.eururo.2014.09.018.
       Full Text
    • Garcia-Reyes, Kirema, Niccolò M. Passoni, Mark L. Palmeri, Christopher R. Kauffman, Kingshuk Roy Choudhury, Thomas J. Polascik, and Rajan T. Gupta. “Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis..” Abdominal Imaging 40, no. 1 (January 2015): 134–42. https://doi.org/10.1007/s00261-014-0197-7.
       Full Text
    • Palmeri, Mark L., Zachary A. Miller, Tyler J. Glass, Kirema Garcia-Reyes, Rajan T. Gupta, Stephen J. Rosenzweig, Christopher Kauffman, et al. “B-mode and acoustic radiation force impulse (ARFI) imaging of prostate zonal anatomy: comparison with 3T T2-weighted MR imaging..” Ultrasonic Imaging 37, no. 1 (January 2015): 22–41. https://doi.org/10.1177/0161734614542177.
       Full Text
    • Gupta, R. T., T. J. Polascik, S. S. Taneja, and A. B. Rosenkrantz. “Recent Developments in Multiparametric Prostate MR Imaging.” Current Radiology Reports 2, no. 12 (December 14, 2014). https://doi.org/10.1007/s40134-014-0074-8.
       Full Text
    • Polascik, Thomas J., Niccolo’ M. Passoni, Arnauld Villers, and Peter L. Choyke. “Modernizing the diagnostic and decision-making pathway for prostate cancer..” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 20, no. 24 (December 2014): 6254–57. https://doi.org/10.1158/1078-0432.CCR-14-0247.
       Full Text
    • Stewart, Suzanne B., Judd W. Moul, Thomas J. Polascik, Bridget F. Koontz, Cary N. Robertson, Stephen J. Freedland, Daniel J. George, W Robert Lee, Andrew J. Armstrong, and Lionel L. Bañez. “Does the multidisciplinary approach improve oncological outcomes in men undergoing surgical treatment for prostate cancer?.” International Journal of Urology : Official Journal of the Japanese Urological Association 21, no. 12 (December 2014): 1215–19. https://doi.org/10.1111/iju.12561.
       Full Text
    • Gupta, Rajan T., Kamil F. Faridi, Abhay A. Singh, Niccolò M. Passoni, Kirema Garcia-Reyes, John F. Madden, and Thomas J. Polascik. “Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy..” Urologic Oncology 32, no. 8 (November 2014): 1292–99. https://doi.org/10.1016/j.urolonc.2014.04.017.
       Full Text
    • Klotz, Laurence, and Thomas J. Polascik. “Low-risk and very-low-risk prostate cancer: is there a role for focal therapy in the era of active surveillance? Yes, the two approaches complement each other..” Oncology (Williston Park, N.Y.) 28, no. 11 (November 2014): 950-9C3.
    • Muller, Berrend G., Willemien van den Bos, Maurizio Brausi, Francois Cornud, Paolo Gontero, Alexander Kirkham, Peter A. Pinto, et al. “Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project..” Bju International 114, no. 5 (November 2014): 698–707. https://doi.org/10.1111/bju.12548.
       Full Text
    • Valerio, Massimo, Hashim U. Ahmed, Mark Emberton, Nathan Lawrentschuk, Massimo Lazzeri, Rodolfo Montironi, Paul L. Nguyen, John Trachtenberg, and Thomas J. Polascik. “The role of focal therapy in the management of localised prostate cancer: a systematic review..” European Urology 66, no. 4 (October 2014): 732–51. https://doi.org/10.1016/j.eururo.2013.05.048.
       Full Text
    • Bailey, Donald E., Meredith Wallace Kazer, Thomas J. Polascik, and Cary Robertson. “Psychosocial trajectories of men monitoring prostate-specific antigen levels following surgery for prostate cancer..” Oncology Nursing Forum 41, no. 4 (July 2014): 361–68. https://doi.org/10.1188/14.onf.361-368.
       Full Text
    • Qi, Peter, Matvey Tsivian, Michael R. Abern, Niccolo M. Passoni, Kathleen F. McGinley, and Thomas J. Polascik. “Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans..” Urologic Oncology 32, no. 5 (July 2014): 555–60. https://doi.org/10.1016/j.urolonc.2013.11.011.
       Full Text
    • Tsivian, Matvey, Edward N. Rampersaud, Maria del Pilar Laguna Pes, Steven Joniau, Raymond J. Leveillee, William B. Shingleton, Monish Aron, et al. “Small renal mass biopsy--how, what and when: report from an international consensus panel..” Bju Int 113, no. 6 (June 2014): 854–63. https://doi.org/10.1111/bju.12470.
       Full Text  Link to Item
    • Lane, Whitney O., Rex C. Bentley, Herbert I. Hurwitz, Leigh A. Howard, Thomas J. Polascik, Mark R. Anderson, and Dan G. Blazer. “Metastatic ampullary adenocarcinoma presenting as a hydrocele: a case report..” Jop : Journal of the Pancreas 15, no. 3 (May 27, 2014): 266–68. https://doi.org/10.6092/1590-8577/2407.
       Full Text
    • Abern, Michael R., Emelian Scosyrev, Matvey Tsivian, Edward M. Messing, Thomas J. Polascik, and Arkadiusz Z. Dudek. “Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era..” Anticancer Research 34, no. 5 (May 2014): 2405–11.
    • Habib, Ashraf S., Judd W. Moul, Thomas J. Polascik, Cary N. Robertson, Anthony M. Roche, William D. White, Stephen E. Hill, Israel Nosnick, Tong J. Gan, and Tong J. Duke Perioperative Outcome Study Group. “Low central venous pressure versus acute normovolemic hemodilution versus conventional fluid management for reducing blood loss in radical retropubic prostatectomy: a randomized controlled trial..” Current Medical Research and Opinion 30, no. 5 (May 2014): 937–43. https://doi.org/10.1185/03007995.2013.877436.
       Full Text
    • Passoni, Niccolò M., and Thomas J. Polascik. “How to select the right patients for focal therapy of prostate cancer?.” Current Opinion in Urology 24, no. 3 (May 2014): 203–8. https://doi.org/10.1097/mou.0000000000000045.
       Full Text
    • Gupta, R. T., K. F. Faridi, A. A. Singh, N. M. Passoni, K. Garcia-Reyes, J. F. Madden, and T. J. Polascik. “Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.” Urologic Oncology 32, no. 8 (2014): 1292–99. https://doi.org/10.1016/j.urolonc.2014.04.017.
       Full Text
    • Abern, Michael R., Matvey Tsivian, Christopher L. Coogan, Howard L. Kaufman, and Thomas J. Polascik. “Characteristics of patients diagnosed with both melanoma and renal cell cancer..” Cancer Causes & Control : Ccc 24, no. 11 (November 2013): 1925–33. https://doi.org/10.1007/s10552-013-0267-0.
       Full Text
    • Qi, Peter, Matvey Tsivian, Michael R. Abern, Lionel L. Bañez, Ping Tang, Judd W. Moul, and Thomas J. Polascik. “Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml..” Urologic Oncology 31, no. 8 (November 2013): 1527–32. https://doi.org/10.1016/j.urolonc.2012.06.003.
       Full Text
    • Koontz, Bridget F., Brian P. Quaranta, John A. Pura, W. R. Lee, Zeljko Vujaskovic, Leah Gerber, Michael Haake, et al. “Phase 1 trial of neoadjuvant radiation therapy before prostatectomy for high-risk prostate cancer..” International Journal of Radiation Oncology, Biology, Physics 87, no. 1 (September 2013): 88–93. https://doi.org/10.1016/j.ijrobp.2013.05.014.
       Full Text
    • Tsivian, Matvey, Michael R. Abern, John J. Yoo, Paul Evans, Peter Qi, Charles Y. Kim, Michael E. Lipkin, Thomas J. Polascik, and Michael N. Ferrandino. “Radiation exposure associated with dedicated renal mass computed tomography protocol: impact of patient characteristics..” J Endourol 27, no. 9 (September 2013): 1102–6. https://doi.org/10.1089/end.2013.0111.
       Full Text  Link to Item
    • Cosentino, M., A. Breda, F. Sanguedolce, J. Landman, J. -. U. Stolzenburg, P. Verze, J. Rassweiler, et al. “The use of mannitol in partial and live donor nephrectomy: an international survey..” World Journal of Urology 31, no. 4 (August 2013): 977–82. https://doi.org/10.1007/s00345-012-1003-1.
       Full Text
    • Tsivian, Matvey, and Thomas J. Polascik. “Bilateral focal ablation of prostate tissue using low-energy direct current (LEDC): a preclinical canine study..” Bju International 112, no. 4 (August 2013): 526–30. https://doi.org/10.1111/bju.12227.
       Full Text
    • Tsivian, Matvey, Michael R. Abern, Peter Qi, and Thomas J. Polascik. “Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy..” Urology 82, no. 1 (July 2013): 166–70. https://doi.org/10.1016/j.urology.2013.01.071.
       Full Text
    • Abern, Michael R., Matvey Tsivian, and Thomas J. Polascik. “Refining treatment for the men who need it: lessons from the PIVOT trial..” Translational Andrology and Urology 2, no. 2 (June 2013): 82–84. https://doi.org/10.3978/j.issn.2223-4683.2012.09.05.
       Full Text
    • Azrad, Maria, Robin T. Vollmer, John Madden, Mark Dewhirst, Thomas J. Polascik, Denise C. Snyder, Mack T. Ruffin, Judd W. Moul, Dean E. Brenner, and Wendy Demark-Wahnefried. “Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer..” Journal of Medicinal Food 16, no. 4 (April 2013): 357–60. https://doi.org/10.1089/jmf.2012.0159.
       Full Text
    • Gupta, Rajan T., Christopher R. Kauffman, Thomas J. Polascik, Samir S. Taneja, and Andrew B. Rosenkrantz. “The state of prostate MRI in 2013..” Oncology (Williston Park, N.Y.) 27, no. 4 (April 2013): 262–70.
    • Abern, M. R., M. R. Bassett, M. Tsivian, L. L. Bañez, T. J. Polascik, M. N. Ferrandino, C. N. Robertson, S. J. Freedland, and J. W. Moul. “Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center..” Prostate Cancer and Prostatic Diseases 16, no. 1 (March 2013): 85–90. https://doi.org/10.1038/pcan.2012.38.
       Full Text
    • Fu, Qiang, Judd W. Moul, Lionel Bañez, Leon Sun, Vladimir Mouraviev, Donghua Xie, and Thomas J. Polascik. “Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance..” Medical Oncology (Northwood, London, England) 30, no. 1 (March 2013). https://doi.org/10.1007/s12032-012-0326-5.
       Full Text
    • Kimura, M., L. L. Bañez, T. J. Polascik, R. M. Bernal, L. Gerber, C. N. Robertson, C. F. Donatucci, and J. W. Moul. “Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction..” Andrology 1, no. 2 (March 2013): 256–61. https://doi.org/10.1111/j.2047-2927.2012.00036.x.
       Full Text
    • Tsivian, M., L. L. Bañez, C. J. Keto, M. R. Abern, P. Qi, L. Gerber, J. W. Moul, and T. J. Polascik. “African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center..” Prostate Cancer and Prostatic Diseases 16, no. 1 (March 2013): 91–94. https://doi.org/10.1038/pcan.2012.39.
       Full Text
    • Tsivian, Matvey, Jorge R. Caso, Masaki Kimura, and Thomas J. Polascik. “Renal tumors in solid organ recipients: clinical and pathologic features..” Urologic Oncology 31, no. 2 (February 2013): 255–58. https://doi.org/10.1016/j.urolonc.2010.11.006.
       Full Text
    • Fu, Q., J. W. Moul, L. Bañez, L. Sun, V. Mouraviev, D. Xie, and T. J. Polascik. “Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: reference for active surveillance..” Medical Oncology (Northwood, London, England) 30, no. 1 (2013): 326–326.
    • Tsivian, M., M. R. Abern, and T. J. Polascik. “Evolution of the concept of focal therapy for prostate cancer..” Oncology (Williston Park, N.Y.) 27, no. 1 (January 1, 2013).
    • Tsivian, Matvey, Michael R. Abern, and Thomas J. Polascik. “Evolution of the concept of focal therapy for prostate cancer..” Oncology (Williston Park, N.Y.) 27, no. 1 (January 2013): 64–70.
    • Fu, Qiang, Judd W. Moul, Lionel L. Bañez, Leon Sun, Vladimir Mouraviev, Dongha Xie, and Thomas J. Polascik. “Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer..” Medical Oncology (Northwood, London, England) 29, no. 5 (December 2012): 3339–44. https://doi.org/10.1007/s12032-012-0270-4.
       Full Text
    • Kimura, Masaki, Jorge R. Caso, Lionel L. Bañez, Bridget F. Koontz, Leah Gerber, Cagri Senocak, Craig F. Donatucci, Zeljko Vujaskovic, Judd W. Moul, and Thomas J. Polascik. “Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy..” Bju International 110, no. 11 Pt C (December 2012): E931–38. https://doi.org/10.1111/j.1464-410x.2012.11168.x.
       Full Text
    • Mouraviev, Vladimir, Talaignair N. Venkatraman, Artak Tovmasyan, Masaki Kimura, Matvey Tsivian, Vladimira Mouravieva, Tom J. Polascik, et al. “Mn porphyrins as novel molecular magnetic resonance imaging contrast agents..” Journal of Endourology 26, no. 11 (November 2012): 1420–24. https://doi.org/10.1089/end.2012.0171.
       Full Text
    • Mues, Adam C., Ruslan Korets, Joseph A. Graversen, Ketan K. Badani, Vincent G. Bird, Sara L. Best, Jeffrey A. Cadeddu, et al. “Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience..” Journal of Endourology 26, no. 10 (October 2012): 1361–66. https://doi.org/10.1089/end.2012.0114.
       Full Text
    • Smeenge, Martijn, Jelle Barentsz, David Cosgrove, Jean de la Rosette, Theo de Reijke, Scott Eggener, Ferdinand Frauscher, et al. “Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel..” Bju International 110, no. 7 (October 2012): 942–48. https://doi.org/10.1111/j.1464-410x.2012.11072.x.
       Full Text
    • Westover, Kenneth, Ming-Hui Chen, Judd Moul, Cary Robertson, Thomas Polascik, Daniel Dosoretz, Michael Katin, Sharon Salenius, and Anthony V. D’Amico. “Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer..” Bju International 110, no. 8 (October 2012): 1116–21. https://doi.org/10.1111/j.1464-410x.2012.11012.x.
       Full Text
    • Volpe, Alessandro, Antonio Finelli, Inderbir S. Gill, Michael A. S. Jewett, Guido Martignoni, Thomas J. Polascik, Mesut Remzi, and Robert G. Uzzo. “Rationale for percutaneous biopsy and histologic characterisation of renal tumours..” European Urology 62, no. 3 (September 2012): 491–504. https://doi.org/10.1016/j.eururo.2012.05.009.
       Full Text
    • Abern, Michael R., Matvey Tsivian, Thomas J. Polascik, and Christopher L. Coogan. “Characteristics and outcomes of tumors arising from the distal nephron..” Urology 80, no. 1 (July 2012): 140–46. https://doi.org/10.1016/j.urology.2012.03.034.
       Full Text
    • Caso, Jorge R., Matvey Tsivian, Vladimir Mouraviev, and Thomas J. Polascik. “Predicting biopsy-proven prostate cancer recurrence following cryosurgery..” Urologic Oncology 30, no. 4 (July 2012): 391–95. https://doi.org/10.1016/j.urolonc.2010.04.001.
       Full Text
    • Ahmed, Hashim U., Oguz Akin, Jonathan A. Coleman, Sarah Crane, Mark Emberton, Larry Goldenberg, Hedvig Hricak, et al. “Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer..” Bju International 109, no. 11 (June 2012): 1636–47. https://doi.org/10.1111/j.1464-410X.2011.10633.x.
       Full Text
    • Kimura, Masaki, Zahid N. Rabbani, Andrew R. Zodda, Hui Yan, Isabel L. Jackson, Thomas J. Polascik, Craig F. Donatucci, Judd W. Moul, Zeljko Vujaskovic, and Bridget F. Koontz. “Role of oxidative stress in a rat model of radiation-induced erectile dysfunction..” The Journal of Sexual Medicine 9, no. 6 (June 2012): 1535–49. https://doi.org/10.1111/j.1743-6109.2012.02716.x.
       Full Text
    • Abern, Michael R., Matvey Tsivian, and Thomas J. Polascik. “Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria..” Current Urology Reports 13, no. 2 (April 2012): 160–69. https://doi.org/10.1007/s11934-012-0241-5.
       Full Text
    • Kimura, Masaki, Lionel L. Bañez, Leah Gerber, Jim Qi, Matvey Tsivian, Stephen J. Freedland, Takefumi Satoh, Thomas J. Polascik, Shiro Baba, and Judd W. Moul. “Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database..” The Journal of Sexual Medicine 9, no. 4 (April 2012): 1174–81. https://doi.org/10.1111/j.1743-6109.2011.02547.x.
       Full Text
    • Tsivian, Matvey, Charles Y. Kim, Jorge R. Caso, Michael D. Rosenberg, Rendon C. Nelson, and Thomas J. Polascik. “Contrast enhancement on computed tomography after renal cryoablation: an evidence of treatment failure?.” Journal of Endourology 26, no. 4 (April 2012): 330–35. https://doi.org/10.1089/end.2011.0337.
       Full Text
    • Wattson, Daniel A., Ming-Hui Chen, Brian J. Moran, Daniel E. Dosoretz, Michelle H. Braccioforte, Sharon A. Salenius, and Anthony V. D’Amico. “The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection..” International Journal of Radiation Oncology, Biology, Physics 82, no. 5 (April 2012): e773–79. https://doi.org/10.1016/j.ijrobp.2011.11.023.
       Full Text
    • Baust, John M., Daniel P. Klossner, Anthony Robilotto, Robert G. Vanbuskirk, Andrew A. Gage, Vladimir Mouraviev, Thomas J. Polascik, and John G. Baust. “Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis..” Bju International 109, no. 6 (March 2012): 949–58. https://doi.org/10.1111/j.1464-410X.2011.10408.x.
       Full Text
    • Caso, Jorge R., Matvey Tsivian, Vladimir Mouraviev, Masaki Kimura, and Thomas J. Polascik. “Complications and postoperative events after cryosurgery for prostate cancer..” Bju International 109, no. 6 (March 2012): 840–45. https://doi.org/10.1111/j.1464-410x.2011.10423.x.
       Full Text
    • Tsivian, Matvey, Tiera Wright, Marva Price, Vladimir Mouraviev, John F. Madden, Masaki Kimura, Terrence Wong, and Thomas J. Polascik. “111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer..” Urologic Oncology 30, no. 2 (March 2012): 150–54. https://doi.org/10.1016/j.urolonc.2009.12.005.
       Full Text
    • Azrad, Maria, Kui Zhang, Robin T. Vollmer, John Madden, Thomas J. Polascik, Denise C. Snyder, Mack T. Ruffin, et al. “Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism..” Plos One 7, no. 12 (January 2012). https://doi.org/10.1371/journal.pone.0053104.
       Full Text  Open Access Copy
    • Fu, Qiang, Judd W. Moul, Lionel L. Bañez, Leon Sun, Vladimir Mouraviev, Donghua Xie, and Thomas J. Polascik. “Preoperative predictors of pathologic stage T2a in low-risk prostate cancer: implications for focal therapy..” Urologia Internationalis 89, no. 3 (January 2012): 296–300. https://doi.org/10.1159/000341556.
       Full Text
    • Smeenge, M., J. Barentsz, D. Cosgrove, J. D. L. Rosette, T. D. Reijke, S. Eggener, F. Frauscher, et al. “Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a Consensus Panel.” Bju International 110, no. 7 (2012): 942–48. https://doi.org/10.1111/j.1464-410X.2012.11072.x.
       Full Text
    • Stewart, Suzanne Biehn, Lionel L. Bañez, Cary N. Robertson, Stephen J. Freedland, Thomas J. Polascik, Donghua Xie, Bridget F. Koontz, et al. “Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center..” The Journal of Urology 187, no. 1 (January 2012): 103–8. https://doi.org/10.1016/j.juro.2011.09.040.
       Full Text
    • Tsivian, Matvey, Daniel M. Moreira, Leon Sun, Vladimir Mouraviev, Masaki Kimura, Judd W. Moul, and Thomas J. Polascik. “Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight..” Urologic Oncology 30, no. 1 (January 2012): 21–25. https://doi.org/10.1016/j.urolonc.2009.11.001.
       Full Text
    • Tsivian, Matvey, Peter Qi, Masaki Kimura, Valerie H. Chen, Stephanie H. Chen, Tong J. Gan, and Thomas J. Polascik. “The effect of noise-cancelling headphones or music on pain perception and anxiety in men undergoing transrectal prostate biopsy..” Urology 79, no. 1 (January 2012): 32–36. https://doi.org/10.1016/j.urology.2011.09.037.
       Full Text
    • Zhai, Liang, Thomas J. Polascik, Wen-Chi Foo, Stephen Rosenzweig, Mark L. Palmeri, John Madden, and Kathryn R. Nightingale. “Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration..” Ultrasound in Medicine & Biology 38, no. 1 (January 2012): 50–61. https://doi.org/10.1016/j.ultrasmedbio.2011.10.002.
       Full Text
    • Mouraviev, Vladimir, Talaignair N. Venkatraman, Artak Tovmasyan, Masaki Kimura, Matvey Tsivian, Vladimira Mouravieva, Tom J. Polascik, et al. “Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents..” Journal of Endourology, November 3, 2011, 1420–24. https://doi.org/10.1089/end.2011.0133.
       Full Text
    • Heymach, John V., Terry J. Shackleford, Hai T. Tran, Suk-Young Yoo, Kim-Anh Do, Melanie Wergin, Pierre Saintigny, et al. “Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer..” Cancer Prevention Research (Philadelphia, Pa.) 4, no. 10 (October 2011): 1590–98. https://doi.org/10.1158/1940-6207.CAPR-10-0136.
       Full Text
    • Kimura, Masaki, Lionel L. Bañez, Florian R. Schroeck, Leah Gerber, Jim Qi, Takefumi Satoh, Shiro Baba, et al. “Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy..” The Journal of Sexual Medicine 8, no. 10 (October 2011): 2935–43. https://doi.org/10.1111/j.1743-6109.2011.02387.x.
       Full Text
    • Mouraviev, Vladimir, Arnauld Villers, David G. Bostwick, Thomas M. Wheeler, Rodolfo Montironi, and Thomas J. Polascik. “Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy..” Bju International 108, no. 7 (October 2011): 1074–85. https://doi.org/10.1111/j.1464-410x.2010.10039.x.
       Full Text
    • Van Poppel, Hein, Frank Becker, Jeffrey A. Cadeddu, Inderbir S. Gill, Gunther Janetschek, Michael A. S. Jewett, M Pilar Laguna, et al. “Treatment of localised renal cell carcinoma..” Eur Urol 60, no. 4 (October 2011): 662–72. https://doi.org/10.1016/j.eururo.2011.06.040.
       Full Text  Link to Item
    • Cotter, Shane E., Ming Hui Chen, Judd W. Moul, W Robert Lee, Bridget F. Koontz, Mitchell S. Anscher, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, and Anthony V. D’Amico. “Salvage radiation in men after prostate-specific antigen failure and the risk of death..” Cancer 117, no. 17 (September 2011): 3925–32. https://doi.org/10.1002/cncr.25993.
       Full Text
    • Kimura, Masaki, Hui Yan, Zahid Rabbani, Takefumi Satoh, Shiro Baba, Fang-fang Yin, Thomas J. Polascik, Craig F. Donatucci, Zeljko Vujaskovic, and Bridget F. Koontz. “Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model..” The Journal of Sexual Medicine 8, no. 8 (August 2011): 2215–26. https://doi.org/10.1111/j.1743-6109.2011.02351.x.
       Full Text
    • Tsivian, Matvey, Jorge Caso, Masaki Kimura, and Thomas J. Polascik. “Renal function outcomes after laparoscopic renal cryoablation..” Journal of Endourology 25, no. 8 (August 2011): 1287–91. https://doi.org/10.1089/end.2011.0017.
       Full Text
    • Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, and Judd W. Moul. “Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men..” Bju International 108, no. 1 (July 2011): 44–48. https://doi.org/10.1111/j.1464-410x.2010.09812.x.
       Full Text
    • Santucci, K. L., K. K. Snyder, J. M. Baust, R. G. Van Buskirk, V. Mouraviev, T. J. Polascik, A. A. Gage, and J. G. Baust. “Use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model..” Prostate Cancer and Prostatic Diseases 14, no. 2 (June 2011): 97–104. https://doi.org/10.1038/pcan.2010.52.
       Full Text
    • Tsivian, Matvey, Daniel M. Moreira, Jorge R. Caso, Vladimir Mouraviev, and Thomas J. Polascik. “Cigarette smoking is associated with advanced renal cell carcinoma..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 29, no. 15 (May 2011): 2027–31. https://doi.org/10.1200/jco.2010.30.9484.
       Full Text
    • Rosenberg, Michael D., Charles Y. Kim, Matvey Tsivian, Matthew N. Suberlak, David R. Sopko, Thomas J. Polascik, and Rendon C. Nelson. “Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications..” Ajr. American Journal of Roentgenology 196, no. 4 (April 2011): 935–39. https://doi.org/10.2214/ajr.10.5182.
       Full Text
    • Kimura, M., C. F. Donatucci, M. Tsivian, J. R. Caso, D. M. Moreira, V. Mouraviev, T. Satoh, S. Baba, and T. J. Polascik. “On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation..” International Journal of Impotence Research 23, no. 2 (March 3, 2011): 49–55. https://doi.org/10.1038/ijir.2011.3.
       Full Text
    • Mayes, Janice M., Vladimir Mouraviev, Leon Sun, Matvey Tsivian, John F. Madden, and Thomas J. Polascik. “Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?.” Urologic Oncology 29, no. 2 (March 2011): 166–70. https://doi.org/10.1016/j.urolonc.2009.03.011.
       Full Text
    • Tsivian, Matvey, Vladimir Mouraviev, David M. Albala, Jorge R. Caso, Cary N. Robertson, John F. Madden, and Thomas J. Polascik. “Clinical predictors of renal mass pathological features..” Bju International 107, no. 5 (March 2011): 735–40. https://doi.org/10.1111/j.1464-410x.2010.09629.x.
       Full Text
    • Mouraviev, Vladimir, and Thomas J. Polascik. “New Frontiers in Imaging and Focal Therapy: Highlights From the Third International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer, February 24-27, 2010, Washington, DC..” Reviews in Urology 13, no. 2 (January 2011): 104–11.
    • Caso, Jorge R., Matvey Tsivian, Vladimir Mouraviev, Thomas J. Polascik, and Judd W. Moul. “Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer..” Bju International 106, no. 11 (December 2010): 1623–27. https://doi.org/10.1111/j.1464-410x.2010.09439.x.
       Full Text
    • D’Amico, Anthony V., Ming-Hui Chen, Leon Sun, W Robert Lee, Vladimir Mouraviev, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, David M. Albala, and Judd W. Moul. “Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death..” Bju International 106, no. 11 (December 2010): 1618–22. https://doi.org/10.1111/j.1464-410x.2010.09447.x.
       Full Text
    • Kimura, Masaki, Vladimir Mouraviev, Matvey Tsivian, Daniel M. Moreira, Janice M. Mayes, and Thomas J. Polascik. “Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation..” Urology 76, no. 5 (November 2010): 1258–65. https://doi.org/10.1016/j.urology.2009.09.062.
       Full Text
    • Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, David M. Albala, Craig F. Donatucci, and Judd W. Moul. “Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men..” Urology 76, no. 5 (November 2010): 1058–62. https://doi.org/10.1016/j.urology.2009.09.049.
       Full Text
    • Caire, Arthur A., Leon Sun, Thomas J. Polascik, David M. Albala, and Judd W. Moul. “Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans..” Bju International 106, no. 8 (October 2010): 1157–60. https://doi.org/10.1111/j.1464-410x.2010.09340.x.
       Full Text
    • Tang, Ping, Leon Sun, Matthew A. Uhlman, Thomas J. Polascik, Stephen J. Freedland, and Judd W. Moul. “Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience..” Cancer 116, no. 20 (October 2010): 4711–17. https://doi.org/10.1002/cncr.25447.
       Full Text
    • Zhai, Liang, John Madden, Wen-Chi Foo, Vladimir Mouraviev, Thomas J. Polascik, Mark L. Palmeri, and Kathryn R. Nightingale. “Characterizing stiffness of human prostates using acoustic radiation force..” Ultrasonic Imaging 32, no. 4 (October 2010): 201–13. https://doi.org/10.1177/016173461003200401.
       Full Text
    • Caire, A. A., L. Sun, B. D. Lack, K. Lum, P. Tang, D. A. Stackhouse, C. N. Robertson, et al. “Predicting non-organ-confined prostate cancer in men diagnosed after 2000..” Prostate Cancer and Prostatic Diseases 13, no. 3 (September 2010): 248–51. https://doi.org/10.1038/pcan.2010.15.
       Full Text
    • Kimura, Masaki, Zahid Rabbani, Vladimir Mouraviev, Matvey Tsivian, Jorge Caso, Takefumi Satoh, Shiro Baba, et al. “Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study..” Urology 76, no. 3 (September 2010): 764.e14-764.e20. https://doi.org/10.1016/j.urology.2010.03.041.
       Full Text
    • Kimura, Masaki, Zahid Rabbani, Vladimir Mouraviev, Matvey Tsivian, Zeljko Vujaskovic, Takefumi Satoh, Shiro Baba, John M. Baust, John G. Baust, and Thomas J. Polascik. “Morphology of hypoxia following cryoablation in a prostate cancer murine model: its relationship to necrosis, apoptosis and, microvessel density..” Cryobiology 61, no. 1 (August 2010): 148–54. https://doi.org/10.1016/j.cryobiol.2010.06.010.
       Full Text
    • Eggener, Scott, Georg Salomon, Peter T. Scardino, Jean De la Rosette, Thomas J. Polascik, and Simon Brewster. “Focal therapy for prostate cancer: possibilities and limitations..” European Urology 58, no. 1 (July 2010): 57–64. https://doi.org/10.1016/j.eururo.2010.03.034.
       Full Text
    • Tsivian, Matvey, Daniel M. Moreira, Jorge R. Caso, Vladimir Mouraviev, John F. Madden, Gennady Bratslavsky, Cary N. Robertson, David M. Albala, and Thomas J. Polascik. “Predicting occult multifocality of renal cell carcinoma..” European Urology 58, no. 1 (July 2010): 118–26. https://doi.org/10.1016/j.eururo.2010.03.011.
       Full Text
    • Tsivian, Matvey, Valerie H. Chen, Charles Y. Kim, Dorit E. Zilberman, Vladimir Mouraviev, Rendon C. Nelson, David M. Albala, and Thomas J. Polascik. “Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center..” European Urology 58, no. 1 (July 2010): 142–47. https://doi.org/10.1016/j.eururo.2010.03.035.
       Full Text
    • Baust, J. G., D. P. Klossner, R. G. Vanbuskirk, A. A. Gage, V. Mouraviev, T. J. Polascik, and J. M. Baust. “Integrin involvement in freeze resistance of androgen-insensitive prostate cancer..” Prostate Cancer and Prostatic Diseases 13, no. 2 (June 2010): 151–61. https://doi.org/10.1038/pcan.2009.59.
       Full Text
    • Caire, Arthur A., Leon Sun, Cary N. Robertson, Thomas J. Polascik, Kelly E. Maloney, Daniel J. George, Marva M. Price, et al. “Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75..” Urology 75, no. 5 (May 2010): 1122–27. https://doi.org/10.1016/j.urology.2009.06.091.
       Full Text
    • Caso, Jorge R., Vladimir Mouraviev, Matvey Tsivian, Thomas J. Polascik, and Judd W. Moul. “Prostate cancer: an evolving paradigm..” Journal of Endourology 24, no. 5 (May 2010): 805–9. https://doi.org/10.1089/end.2009.0539.
       Full Text  Open Access Copy
    • Mouraviev, Vladimir, Truls Erik Bjerklund Johansen, and Thomas J. Polascik. “Contemporary results of focal therapy for prostate cancer using cryoablation..” Journal of Endourology 24, no. 5 (May 2010): 827–34. https://doi.org/10.1089/end.2009.0546.
       Full Text  Open Access Copy
    • Rosette, J. de la, H. Ahmed, J. Barentsz, T Bjerklund Johansen, M. Brausi, M. Emberton, F. Frauscher, et al. “Focal therapy in prostate cancer-report from a consensus panel..” Journal of Endourology 24, no. 5 (May 2010): 775–80. https://doi.org/10.1089/end.2009.0596.
       Full Text  Open Access Copy
    • Tsivian, Matvey, Marcel Hruza, Vladimir Mouraviev, Jens Rassweiler, and Thomas J. Polascik. “Prostate biopsy in selecting candidates for hemiablative focal therapy..” Journal of Endourology 24, no. 5 (May 2010): 849–53. https://doi.org/10.1089/end.2009.0473.
       Full Text  Open Access Copy
    • Tsivian, Matvey, and Thomas J. Polascik. “Focal cryotherapy for prostate cancer..” Current Urology Reports 11, no. 3 (May 2010): 147–51. https://doi.org/10.1007/s11934-010-0100-1.
       Full Text
    • Choueiri, Toni K., Ming-Hui Chen, Anthony V. D’Amico, Leon Sun, Paul L. Nguyen, Julia H. Hayes, Cary N. Robertson, et al. “Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death..” Cancer 116, no. 8 (April 2010): 1887–92. https://doi.org/10.1002/cncr.25013.
       Full Text
    • Tsivian, Matvey, Masaki Kimura, Leon Sun, Vladimir Mouraviev, Janice M. Mayes, and Thomas J. Polascik. “Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended..” Bju International 105, no. 8 (April 2010): 1089–92. https://doi.org/10.1111/j.1464-410x.2009.08904.x.
       Full Text
    • Zhai, Liang, John Madden, Wen-Chi Foo, Mark L. Palmeri, Vladimir Mouraviev, Thomas J. Polascik, and Kathryn R. Nightingale. “Acoustic radiation force impulse imaging of human prostates ex vivo..” Ultrasound in Medicine & Biology 36, no. 4 (April 2010): 576–88. https://doi.org/10.1016/j.ultrasmedbio.2009.12.006.
       Full Text
    • Kimura, Masaki, Shiro Baba, and Thomas J. Polascik. “Minimally invasive surgery using ablative modalities for the localized renal mass..” International Journal of Urology : Official Journal of the Japanese Urological Association 17, no. 3 (March 2010): 215–27. https://doi.org/10.1111/j.1442-2042.2009.02445.x.
       Full Text
    • Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, David M. Albala, Craig F. Donatucci, and Judd W. Moul. “Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk..” The Journal of Urology 183, no. 3 (March 2010): 946–50. https://doi.org/10.1016/j.juro.2009.11.021.
       Full Text
    • Uhlman, Matthew A., Leon Sun, Danielle A. Stackhouse, Thomas J. Polascik, Valdmir Mouraviev, Cary N. Robertson, David M. Albala, and Judd W. Moul. “Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate..” The Journal of Urology 183, no. 3 (March 2010): 997–1001. https://doi.org/10.1016/j.juro.2009.11.046.
       Full Text
    • Tsivian, Matvey, John C. Lyne, Janice M. Mayes, Vladimir Mouraviev, Masaki Kimura, and Thomas J. Polascik. “Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation..” Urology 75, no. 2 (February 2010): 307–10. https://doi.org/10.1016/j.urology.2009.09.039.
       Full Text
    • Uhlman, Matthew A., Leon Sun, Danielle A. Stackhouse, Arthur A. Caire, Thomas J. Polascik, Cary N. Robertson, John Madden, Robin Vollmer, David M. Albala, and Judd W. Moul. “Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?.” Urology 75, no. 2 (February 2010): 460–66. https://doi.org/10.1016/j.urology.2009.06.059.
       Full Text
    • Uhlman, Matthew A., Leon Sun, Danielle A. Stackhouse, Arthur A. Caire, Thomas J. Polascik, Cary N. Robertson, John Madden, Robin Vollmer, David M. Albala, and Judd W. Moul. “Tumor Volume, Tumor Percentage Involvement, or Prostate Volume: Which Is Predictive of Prostate-specific Antigen Recurrence?.” Urology 75, no. 2 (February 2010): 460–66. https://doi.org/10.1016/j.urology.2009.06.059.
       Full Text  Link to Item
    • Tsivian, Matvey, and Thomas J. Polascik. “Recent advances in focal therapy of prostate and kidney cancer..” F1000 Medicine Reports 2 (January 18, 2010): 1451–52. https://doi.org/10.3410/M2-1.
       Full Text
    • Kimura, Masaki, Vladimir Mouraviev, Matvey Tsivian, Janice M. Mayes, Takefumi Satoh, and Thomas J. Polascik. “Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy..” Bju International 105, no. 2 (January 2010): 191–201. https://doi.org/10.1111/j.1464-410x.2009.08715.x.
       Full Text
    • Kimura, Masaki, Matvey Tsivian, Vladimir Mouraviev, Janice M. Mayes, Marva M. Price, Michael C. Bannister, John F. Madden, Terence Z. Wong, and Thomas J. Polascik. “Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy..” International Journal of Urology : Official Journal of the Japanese Urological Association 16, no. 12 (December 2009): 971–75. https://doi.org/10.1111/j.1442-2042.2009.02413.x.
       Full Text
    • Sun, Leon, Arthur A. Caire, Cary N. Robertson, Daniel J. George, Thomas J. Polascik, Kelly E. Maloney, Philip J. Walther, et al. “Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras..” The Journal of Urology 182, no. 5 (November 2009): 2242–48. https://doi.org/10.1016/j.juro.2009.07.034.
       Full Text
    • Tsivian, Matvey, Janice M. Mayes, Tracey L. Krupski, Vladimir Mouraviev, Craig F. Donatucci, and Thomas J. Polascik. “Altered male physiologic function after surgery for prostate cancer: couple perspective..” International Braz J Urol : Official Journal of the Brazilian Society of Urology 35, no. 6 (November 2009): 673–82. https://doi.org/10.1590/s1677-55382009000600006.
       Full Text
    • Tsivian, Matvey, Leon Sun, Vladimir Mouraviev, John F. Madden, Janice M. Mayes, Judd W. Moul, and Thomas J. Polascik. “Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy..” Urology 74, no. 5 (November 2009): 1090–93. https://doi.org/10.1016/j.urology.2009.03.043.
       Full Text
    • Polascik, Thomas J., and Vladimir Mouraviev. “Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients..” Urology 74, no. 4 (October 2009): 726–30. https://doi.org/10.1016/j.urology.2009.02.084.
       Full Text
    • Polascik, Thomas J. “Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases..” Drug Design, Development and Therapy 3 (September 21, 2009): 27–40.
    • Caire, Arthur A., Leon Sun, Oludotun Ode, Danielle A. Stackhouse, Kelly Maloney, Craig Donatucci, Vladimir Mouraviev, et al. “Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?.” Urology 74, no. 3 (September 2009): 643–47. https://doi.org/10.1016/j.urology.2009.02.049.
       Full Text
    • Mouraviev, Vladimir, John F. Madden, Gloria Broadwater, Janice M. Mayes, James L. Burchette, Frank Schneider, Jill Smith, Matvey Tsivian, Terence Wong, and Thomas J. Polascik. “Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland..” The Journal of Urology 182, no. 3 (September 2009): 938–47. https://doi.org/10.1016/j.juro.2009.05.047.
       Full Text
    • Xu, David D., Sandy D. Sun, Flint Wang, Leon Sun, Danielle Stackhouse, Thomas Polascik, David M. Albala, Judd W. Moul, Arthur Caire, and Cary N. Robertson. “Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomy..” Urology 74, no. 3 (September 2009): 654–58. https://doi.org/10.1016/j.urology.2008.12.063.
       Full Text
    • D’Alonzo, Richard C., Tong J. Gan, Judd W. Moul, David M. Albala, Thomas J. Polascik, Cary N. Robertson, Leon Sun, Philipp Dahm, and Ashraf S. Habib. “A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomy..” Journal of Clinical Anesthesia 21, no. 5 (August 22, 2009): 322–28. https://doi.org/10.1016/j.jclinane.2008.09.005.
       Full Text
    • Mayes, J. M., V. Mouraviev, M. Tsivian, T. L. Krupski, C. F. Donatucci, and T. J. Polascik. “Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer..” International Journal of Impotence Research 21, no. 4 (July 2009): 253–60. https://doi.org/10.1038/ijir.2009.23.
       Full Text
    • Stackhouse, Danielle A., Leon Sun, Florian R. Schroeck, Jayakrishnan Jayachandran, Arthur A. Caire, Cyril O. Acholo, Cary N. Robertson, et al. “Factors predicting prostatic biopsy Gleason sum under grading..” The Journal of Urology 182, no. 1 (July 2009): 118–22. https://doi.org/10.1016/j.juro.2009.02.127.
       Full Text
    • Habib, Ashraf S., Thomas J. Polascik, Alon Z. Weizer, William D. White, Judd W. Moul, Magdi A. ElGasim, and Tong J. Gan. “Lidocaine patch for postoperative analgesia after radical retropubic prostatectomy..” Anesthesia and Analgesia 108, no. 6 (June 2009): 1950–53. https://doi.org/10.1213/ane.0b013e3181a21185.
       Full Text
    • Polascik, Thomas J., Janice M. Mayes, Florian R. Schroeck, Leon Sun, John F. Madden, Judd W. Moul, and Vladimir Mouraviev. “Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy..” Cancer 115, no. 10 (May 2009): 2104–10. https://doi.org/10.1002/cncr.24258.
       Full Text
    • Caire, Arthur A., Leon Sun, Thomas J. Polascik, Cary N. Robertson, Kelly E. Maloney, Craig F. Donatucci, Daivd M. Albala, and Judd W. Moul. “PREDICTING NON-ORGAN CONFINED PROSTATE CANCER AFTER THE YEAR 2000.” The Journal of Urology 181, no. 4 (April 2009): 609–609. https://doi.org/10.1016/s0022-5347(09)61710-9.
       Full Text
    • Chen, Valerie H., Vladimir Mouraviev, Janice M. Mayes, Leon Sun, John F. Madden, Judd W. Moul, and Thomas J. Polascik. “Utility of a 3-dimensional transrectal ultrasound-guided prostate biopsy system for prostate cancer detection..” Technology in Cancer Research & Treatment 8, no. 2 (April 2009): 99–104. https://doi.org/10.1177/153303460900800202.
       Full Text
    • Lack, Benjamin D., Leon Sun, Arthur A. Caire, Craig F. Donatucci, Cary N. Robertson, Vladimir Mouraviev, Thomas J. Polascik, et al. “WHO DOES NOT NEED FOLLOW UP TWO YEARS AFTER PROSTATECTOMY? AN ANALYSIS OF 1739 PATIENTS AT DUKE UNIVERSITY MEDICAL CENTER.” Journal of Urology 181, no. 4S (April 2009): 759–759. https://doi.org/10.1016/s0022-5347(09)62115-7.
       Full Text
    • Lack, Benjamin D., Leon Sun, Arthur A. Caire, Oludotun Ode, Danielle A. Stackhouse, Kelly E. Maloney, Craig F. Donatucci, et al. “DELAYED PSA RECURRENCE AFTER RADICAL PROSTATECTOMY: HOW TO IDENTIFY PATIENTS AT RISK AND THEIR CLINICAL OUTCOMES?.” Journal of Urology 181, no. 4S (April 2009): 457–457. https://doi.org/10.1016/s0022-5347(09)61296-9.
       Full Text
    • Moul, Judd W., Leon Sun, Benjamin D. Lack, Cary N. Robertson, Thomas J. Polascik, Craig F. Donatucci, Kelly E. Maloney, Marva Price, David M. Albala, and Arthur A. Caire. “SAY NO TO THE US PREVENTATIVE TASK FORCE RECOMMENDATION TO NO LONGER OFFER PROSTATE CANCER SCREENING AFTER AGE 75?.” Journal of Urology 181, no. 4S (April 2009): 797–797. https://doi.org/10.1016/s0022-5347(09)62222-9.
       Full Text
    • Mouraviev, Vladimir, Janice M. Mayes, and Thomas J. Polascik. “Pathologic basis of focal therapy for early-stage prostate cancer..” Nature Reviews. Urology 6, no. 4 (April 2009): 205–15. https://doi.org/10.1038/nrurol.2009.29.
       Full Text
    • Rosette, J. J. M. C. H. de la, V. Mouraviev, and T. J. Polascik. “Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate Cancer.” European Urology, Supplements 8, no. 5 (April 1, 2009): 424–32. https://doi.org/10.1016/j.eursup.2009.01.005.
       Full Text
    • Stackhouse, Danielle A., Leon Sun, Philipp Dahm, Louis R. Kavoussi, David Paulson, Craig F. Donatucci, Kelly E. Maloney, et al. “PERINEAL RADICAL PROSTATECTOMY: WHAT ARE THE TEN YEAR OUTCOMES?.” Journal of Urology 181, no. 4S (April 2009): 210–210. https://doi.org/10.1016/s0022-5347(09)60604-2.
       Full Text
    • Moul, Judd W., Vladimir Mouraviev, Leon Sun, Florian R. Schroeck, and Thomas J. Polascik. “Prostate cancer: the new landscape..” Current Opinion in Urology 19, no. 2 (March 2009): 154–60. https://doi.org/10.1097/mou.0b013e328323f5d6.
       Full Text
    • Polascik, Thomas J., Janice M. Mayes, and Vladimir Mouraviev. “Nerve-sparing focal cryoablation of prostate cancer..” Current Opinion in Urology 19, no. 2 (March 2009): 182–87. https://doi.org/10.1097/mou.0b013e328323f603.
       Full Text
    • Schroeck, F. R., T. L. Krupski, L. Sun, D. M. Albala, M. M. Price, T. J. Polascik, C. N. Robertson, A. K. Tewari, and J. W. Moul. “Satisfaction and Regret After Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy.” Journal of Urology 181, no. 2 (February 1, 2009): 635–36.
       Link to Item
    • Demark-Wahnefried, Wendy, Thomas J. Polascik, Stephen L. George, Boyd R. Switzer, John F. Madden, Mack T. Ruffin, Denise C. Snyder, et al. “Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery..” Cancer Epidemiol Biomarkers Prev 17, no. 12 (December 2008): 3577–87. https://doi.org/10.1158/1055-9965.EPI-08-0008.
       Full Text  Link to Item
    • Schroeck, Florian R., Craig F. Donatucci, Emily C. Smathers, Leon Sun, David M. Albala, Thomas J. Polascik, Judd W. Moul, and Tracey L. Krupski. “Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite..” Cancer 113, no. 10 (November 2008): 2687–94. https://doi.org/10.1002/cncr.23887.
       Full Text
    • Stein, Alexandra J., Janice M. Mayes, Vladimir Mouraviev, Valerie H. Chen, Rendon C. Nelson, and Thomas J. Polascik. “Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor..” Journal of Endourology 22, no. 11 (November 2008): 2433–39. https://doi.org/10.1089/end.2008.0261.
       Full Text
    • Isariyawongse, Brandon K., Leon Sun, Lionel L. Bañez, Cary Robertson, Thomas J. Polascik, Kelly Maloney, Craig Donatucci, et al. “Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen..” Urology 72, no. 4 (October 2008): 882–86. https://doi.org/10.1016/j.urology.2008.02.021.
       Full Text
    • Schroeck, Florian R., Tracey L. Krupski, Leon Sun, David M. Albala, Marva M. Price, Thomas J. Polascik, Cary N. Robertson, Alok K. Tewari, and Judd W. Moul. “Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy..” European Urology 54, no. 4 (October 2008): 785–93. https://doi.org/10.1016/j.eururo.2008.06.063.
       Full Text
    • Chen, Valerie H., Janice M. Mayes, Vladimir Mouraviev, and Thomas J. Polascik. “Urothelial sloughing with obstruction after laparoscopic cryoablation of small renal carcinoma in solitary kidney..” Urology 72, no. 3 (September 2008): 716.e1-716.e2. https://doi.org/10.1016/j.urology.2007.12.067.
       Full Text
    • Habib, Ashraf S., William D. White, Magdi A. El Gasim, Gamal Saleh, Thomas J. Polascik, Judd W. Moul, and Tong J. Gan. “Transdermal nicotine for analgesia after radical retropubic prostatectomy..” Anesthesia and Analgesia 107, no. 3 (September 2008): 999–1004. https://doi.org/10.1213/ane.0b013e31816f2616.
       Full Text
    • Polascik, Thomas J., Janice M. Mayes, Leon Sun, John F. Madden, Judd W. Moul, and Vladimir Mouraviev. “Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy..” The Prostate 68, no. 13 (September 2008): 1380–86. https://doi.org/10.1002/pros.20804.
       Full Text
    • Chen, Valerie H., Janice M. Mayes, John F. Madden, Alexandra J. Stein, Vladimir Mouraviev, and Thomas J. Polascik. “The effect of cryoablation on the histologic interpretation of intraoperative biopsy of small clear cell renal carcinoma and renal oncocytoma..” Journal of Endourology 22, no. 8 (August 2008): 1617–21. https://doi.org/10.1089/end.2008.0156.
       Full Text
    • Mayes, Janice M., Vladimir Mouraviev, and Thomas J. Polascik. “Impact of a cryotherapy training workshop on the adoption and utilization of cryotherapy in the community setting..” The Canadian Journal of Urology 15, no. 4 (August 2008): 4147–52.
    • Megwalu, Ifeanyichukwu I., Genoa G. Ferguson, John T. Wei, Vladimir Mouraviev, Thomas J. Polascik, Samir Taneja, Linda Black, Gerald L. Andriole, and Adam S. Kibel. “Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer..” Bju International 102, no. 5 (August 2008): 546–50. https://doi.org/10.1111/j.1464-410x.2008.07832.x.
       Full Text
    • Polascik, Thomas J., Janice M. Mayes, and Vladimir Mouraviev. “From whole-gland to targeted cryoablation for the treatment of unilateral or focal prostate cancer..” Oncology (Williston Park, N.Y.) 22, no. 8 (July 2008): 900–914.
    • Schroeck, Florian R., Leon Sun, Stephen J. Freedland, David M. Albala, Vladimir Mouraviev, Thomas J. Polascik, and Judd W. Moul. “Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy..” Bju International 102, no. 1 (July 2008): 28–32. https://doi.org/10.1111/j.1464-410x.2008.07607.x.
       Full Text
    • Koontz, Bridget F., Vladimir Mouraviev, Jeffrey L. Johnson, Janice Mayes, Stephanie H. Chen, Terence Z. Wong, Mitchell S. Anscher, Leon Sun, Judd Moul, and Thomas J. Polascik. “Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer..” International Journal of Radiation Oncology, Biology, Physics 71, no. 2 (June 2008): 358–61. https://doi.org/10.1016/j.ijrobp.2007.10.020.
       Full Text
    • Mouraviev, Vladimir, Gloria Broadwater, Leon Sun, Janice M. Mayes, Judd W. Moul, and Thomas J. Polascik. “Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?.” Urology 71, no. 6 (June 2008): 1020–23. https://doi.org/10.1016/j.urology.2007.11.016.
       Full Text
    • Polascik, Thomas J., and Vladimir Mouraviev. “Focal therapy for prostate cancer..” Current Opinion in Urology 18, no. 3 (May 2008): 269–74. https://doi.org/10.1097/mou.0b013e3282f9b3a5.
       Full Text
    • Polascik, Thomas J., and Vladimir Mouraviev. “Zoledronic acid in the management of metastatic bone disease..” Therapeutics and Clinical Risk Management 4, no. 1 (February 2008): 261–68. https://doi.org/10.2147/tcrm.s2707.
       Full Text
    • Demark-Wahnefried, Wendy, Stephen L. George, Boyd R. Switzer, Denise C. Snyder, John F. Madden, Thomas J. Polascik, Mack T. Ruffin, and Robin T. Vollmer. “Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer..” Clinical Trials (London, England) 5, no. 3 (January 2008): 262–72. https://doi.org/10.1177/1740774508091676.
       Full Text
    • Mouraviev, V., and T. J. Polascik. “Avoiding surgery in prostate cancer patients with low-risk disease.” Therapy 5, no. 1 (January 1, 2008): 25–36. https://doi.org/10.2217/14750708.5.1.25.
       Full Text
    • Polascik, T. J. “Bone health in prostate cancer patients receiving androgen-deprivation therapy: the role of bisphosphonates..” Prostate Cancer and Prostatic Diseases 11, no. 1 (January 2008): 13–19. https://doi.org/10.1038/sj.pcan.4501019.
       Full Text
    • Mouraviev, Vladimir, Leon Sun, John F. Madden, Janice M. Mayes, Judd W. Moul, and Thomas J. Polascik. “Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy..” Urology 70, no. 6 (December 2007): 1141–45. https://doi.org/10.1016/j.urology.2007.07.066.
       Full Text
    • Polascik, T. J., I. Nosnik, J. M. Mayes, and V. Mouraviev. “Short Term Clinical Outcome after Laparoscopic Cryoablation of the Renal Tumor < or = 3.5 cm..” Technology in Cancer Research & Treatment 6, no. 6 (December 2007): 621–24. https://doi.org/10.1177/153303460700600605.
       Full Text
    • Chen, Stephanie H., Vladimir Mouraviev, Janice M. Mayes, and Thomas J. Polascik. “Prostatic abscess as a delayed complication following cryosurgery for primary prostate cancer..” The Canadian Journal of Urology 14, no. 4 (August 2007): 3646–48.
    • Mouraviev, Vladimir, Janice M. Mayes, Leon Sun, John F. Madden, Judd W. Moul, and Thomas J. Polascik. “Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer..” Cancer 110, no. 4 (August 2007): 906–10. https://doi.org/10.1002/cncr.22858.
       Full Text
    • Polascik, Thomas J., Israel Nosnik, Janice M. Mayes, and Vladimir Mouraviev. “Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology..” Urology 70, no. 1 (July 2007): 117–21. https://doi.org/10.1016/j.urology.2007.03.027.
       Full Text
    • Chen, Stephanie H., Vladimir Mouraviev, Ganesh V. Raj, Charles G. Marguet, and Thomas J. Polascik. “Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma..” Urology 69, no. 5 (May 2007): 982.e3-982.e5. https://doi.org/10.1016/j.urology.2007.02.031.
       Full Text
    • Marguet, Charles, Ganesh V. Raj, James H. Brashears, Mitchell S. Anscher, Kirk Ludwig, Vladimir Mouraviev, Cary N. Robertson, and Thomas J. Polascik. “Rectourethral fistula after combination radiotherapy for prostate cancer..” Urology 69, no. 5 (May 2007): 898–901. https://doi.org/10.1016/j.urology.2007.01.044.
       Full Text
    • Baust, J. G., A. A. Gage, D. Klossner, D. Clarke, R. Miller, J. Cohen, A. Katz, T. Polascik, H. Clarke, and J. M. Baust. “Issues critical to the successful application of cryosurgical ablation of the prostate..” Technology in Cancer Research & Treatment 6, no. 2 (April 2007): 97–109. https://doi.org/10.1177/153303460700600206.
       Full Text
    • Mouraviev, Vladimir, Janice M. Mayes, John F. Madden, Leon Sun, and Thomas J. Polascik. “Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy..” Technology in Cancer Research & Treatment 6, no. 2 (April 2007): 91–95. https://doi.org/10.1177/153303460700600205.
       Full Text
    • Sun, Leon, Judd W. Moul, James M. Hotaling, Edward Rampersaud, Phillipp Dahm, Cary Robertson, Nicholas Fitzsimons, David Albala, and Thomas J. Polascik. “Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years..” Bju International 99, no. 4 (April 2007): 753–57. https://doi.org/10.1111/j.1464-410x.2006.06682.x.
       Full Text
    • Tseng, Timothy Y., Quinton V. Cancel, Susan F. Fesperman, Hubert R. Kuebler, Leon Sun, Cary N. Robertson, Thomas J. Polascik, et al. “The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy..” The Journal of Urology 177, no. 4 (April 2007): 1318–23. https://doi.org/10.1016/j.juro.2006.11.035.
       Full Text
    • Mouraviev, Vladimir, Israel Nosnik, Cary Robertson, David Albala, Philip Walther, and Thomas J. Polascik. “Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience..” European Urology 51, no. 3 (March 2007): 715–20. https://doi.org/10.1016/j.eururo.2006.06.050.
       Full Text
    • Moul, Judd W., Leon Sun, James M. Hotaling, Nicholas J. Fitzsimons, Thomas J. Polascik, Cary N. Robertson, Philipp Dahm, et al. “Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening..” The Journal of Urology 177, no. 2 (February 2007): 499–503. https://doi.org/10.1016/j.juro.2006.09.063.
       Full Text
    • Mouraviev, Vladimir, Israel Nosnik, Leon Sun, Cary N. Robertson, Philip Walther, David Albala, Judd W. Moul, and Thomas J. Polascik. “Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience..” Urology 69, no. 2 (February 2007): 311–14. https://doi.org/10.1016/j.urology.2006.10.025.
       Full Text
    • Mouraviev, Vladimir, Steven Joniau, Hendrik Van Poppel, and Thomas J. Polascik. “Current status of minimally invasive ablative techniques in the treatment of small renal tumours..” European Urology 51, no. 2 (February 2007): 328–36. https://doi.org/10.1016/j.eururo.2006.09.024.
       Full Text
    • Nosnik, Israel P., Vladimir Mouraviev, Rendon Nelson, and Thomas J. Polascik. “Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma..” Urology 68, no. 6 (December 4, 2006): 1343.e1-1343.e3. https://doi.org/10.1016/j.urology.2006.09.004.
       Full Text
    • Auge, Brian K., Robert W. Santa-Cruz, and Thomas J. Polascik. “Effect of freeze time during renal cryoablation: a swine model..” Journal of Endourology 20, no. 12 (December 2006): 1101–5. https://doi.org/10.1089/end.2006.20.1101.
       Full Text
    • Raj, Ganesh V., Charles Yowell, John F. Madden, Israel Nosnik, Vladimir Mouraviev, and Thomas J. Polascik. “Malignant cystic nephroma..” The Canadian Journal of Urology 13, no. 6 (December 2006): 3348–50.
    • Mouraviev, Vladimir, and Thomas J. Polascik. “Update on cryotherapy for prostate cancer in 2006..” Current Opinion in Urology 16, no. 3 (May 2006): 152–56. https://doi.org/10.1097/01.mou.0000193393.54598.9f.
       Full Text
    • Wiygul, Jeremy B., Costas Lallas, Ari Silverstein, and Thomas J. Polascik. “Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman..” Urology 67, no. 5 (May 2006): 1085.e5-1085.e6. https://doi.org/10.1016/j.urology.2005.11.033.
       Full Text
    • Polascik, T. J. “Preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases.” American Journal of Urology Review 4, no. 3 (April 1, 2006).
    • Mouraviev, V., B. Evans, and T. J. Polascik. “Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach..” Prostate Cancer and Prostatic Diseases 9, no. 1 (January 2006): 99–101. https://doi.org/10.1038/sj.pcan.4500853.
       Full Text
    • Mouraviev, V., and T. J. Polascik. “Laparoscopic ureteroureterostomy for retrocaval ureter.” European Urology, Supplements 5, no. 5 SPEC. ISS. (January 1, 2006): 466–69. https://doi.org/10.1016/j.eursup.2006.02.011.
       Full Text
    • Weizer, Alon Z., Ganesh V. Raj, Martin O’Connell, Cary N. Robertson, Rendon C. Nelson, and Thomas J. Polascik. “Complications after percutaneous radiofrequency ablation of renal tumors..” Urology 66, no. 6 (December 2005): 1176–80. https://doi.org/10.1016/j.urology.2005.06.125.
       Full Text
    • Polascik, Thomas J., Robert W. Given, Charles Metzger, Sydney R. Julian, James C. Vestal, Gary S. Karlin, Craig S. Barkley, David L. Bilhartz, Laura T. McWhorter, and Leo V. Lacerna. “Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases..” Urology 66, no. 5 (November 2005): 1054–59. https://doi.org/10.1016/j.urology.2005.05.035.
       Full Text
    • Wiygul, Jeremy B., Brian R. Evans, Bercedis L. Peterson, Thomas J. Polascik, Philip J. Walther, Cary N. Robertson, David M. Albala, and Wendy Demark-Wahnefried. “Supplement use among men with prostate cancer..” Urology 66, no. 1 (July 2005): 161–66. https://doi.org/10.1016/j.urology.2005.01.035.
       Full Text
    • Brashears, James H., Ganesh V. Raj, Alfonso Crisci, Matthew D. Young, Drew Dylewski, Rendon Nelson, John F. Madden, and Thomas J. Polascik. “Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model..” The Journal of Urology 173, no. 6 (June 2005): 2160–65. https://doi.org/10.1097/01.ju.0000158125.80981.f1.
       Full Text
    • Raj, Ganesh V., James H. Brashears, Ankur Anand, David F. Paulson, and Thomas J. Polascik. “Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?.” Urology 65, no. 2 (February 2005): 332–36. https://doi.org/10.1016/j.urology.2004.09.027.
       Full Text
    • Wong, Terence Z., Timothy G. Turkington, Thomas J. Polascik, and R Edward Coleman. “ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology..” Ajr. American Journal of Roentgenology 184, no. 2 (February 2005): 676–80. https://doi.org/10.2214/ajr.184.2.01840676.
       Full Text
    • Dulaimi, Essel, Inmaculada Ibanez de Caceres, Robert G. Uzzo, Tahseen Al-Saleem, Richard E. Greenberg, Thomas J. Polascik, James S. Babb, William E. Grizzle, and Paul Cairns. “Promoter hypermethylation profile of kidney cancer..” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 10, no. 12 Pt 1 (June 2004): 3972–79. https://doi.org/10.1158/1078-0432.ccr-04-0175.
       Full Text
    • Demark-Wahnefried, Wendy, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, David F. Paulson, and Robin T. Vollmer. “Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen..” Urology 63, no. 5 (May 2004): 900–904. https://doi.org/10.1016/j.urology.2003.12.010.
       Full Text
    • Raj, Ganesh V., Kenneth S. Ellington, and Thomas J. Polascik. “Autoimmune testicular vasculitis..” Urology 61, no. 5 (May 2003).
    • Santa-Cruz, Robert W., Brian K. Auge, Costas D. Lallas, Glenn M. Preminger, and Thomas J. Polascik. “Use of bipolar laparoscopic forceps to occlude and transect the retroperitoneal vasculature: a porcine model..” Journal of Endourology 17, no. 3 (April 2003): 181–85. https://doi.org/10.1089/089277903321618761.
       Full Text
    • Raj, Ganesh V., Donal J. Reddan, Michael F. Hoey, and Thomas J. Polascik. “Management of small renal tumors with radiofrequency ablation..” Urology 61, no. 1 (January 2003): 23–29. https://doi.org/10.1016/s0090-4295(02)01850-2.
       Full Text
    • Polascik, Thomas J., David G. Bostwick, and Paul Cairns. “Molecular genetics and histopathologic features of adult distal nephron tumors..” Urology 60, no. 6 (December 2002): 941–46. https://doi.org/10.1016/s0090-4295(02)01825-3.
       Full Text
    • Munver, Ravi, Chris B. Threatt, Fernando C. Delvecchio, Glenn M. Preminger, and Thomas J. Polascik. “Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study..” Urology 60, no. 1 (July 2002): 170–75. https://doi.org/10.1016/s0090-4295(02)01667-9.
       Full Text
    • Price, David T., R Edward Coleman, Ray P. Liao, Cary N. Robertson, Thomas J. Polascik, and Timothy R. DeGrado. “Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer..” The Journal of Urology 168, no. 1 (July 2002): 273–80. https://doi.org/10.1016/s0022-5347(05)64906-3.
       Full Text
    • Raj, Ganesh V., Alan W. Partin, and Thomas J. Polascik. “Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy..” Cancer 94, no. 4 (February 2002): 987–96. https://doi.org/10.1002/cncr.10337.
       Full Text
    • Demark-Wahnefried, W., D. T. Price, T. J. Polascik, C. N. Robertson, E. E. Anderson, D. F. Paulson, P. J. Walther, M. Gannon, and R. T. Vollmer. “Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features..” Urology 58, no. 1 (July 2001): 47–52.
       Link to Item
    • Reddan, D. N., G. V. Raj, and T. J. Polascik. “Management of small renal tumors: an overview..” The American Journal of Medicine 110, no. 7 (May 2001): 558–62. https://doi.org/10.1016/s0002-9343(01)00650-7.
       Full Text
    • Rosenthal, S. A., M. K. Haseman, and T. J. Polascik. “Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer..” Techniques in Urology 7, no. 1 (March 2001): 27–37.
    • DeGrado, T. R., R. E. Coleman, S. Wang, S. W. Baldwin, M. D. Orr, C. N. Robertson, T. J. Polascik, and D. T. Price. “Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer..” Cancer Research 61, no. 1 (January 2001): 110–17.
    • Munver, R., R. C. Donehower, J. D. Kronz, and T. J. Polascik. “HIV infection presenting as an unusually large pure yolk sac tumor of the testis..” The Journal of Urology 164, no. 5 (November 2000): 1653–54. https://doi.org/10.1097/00005392-200011000-00051.
       Full Text
    • Wolf, J. S., R. Marcovich, I. S. Gill, G. T. Sung, L. R. Kavoussi, R. V. Clayman, E. M. McDougall, et al. “Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery..” Urology 55, no. 6 (June 2000): 831–36. https://doi.org/10.1016/s0090-4295(00)00488-x.
       Full Text
    • Haseman, M. K., S. A. Rosenthal, and T. J. Polascik. “Capromab Pendetide imaging of prostate cancer..” Cancer Biotherapy & Radiopharmaceuticals 15, no. 2 (April 2000): 131–40. https://doi.org/10.1089/cbr.2000.15.131.
       Full Text
    • Polascik, T. J., Z. P. Wang, M. Shue, S. Di, R. T. Gurganus, S. C. Hortopan, P. O. Ts’o, and A. W. Partin. “Influence of sextant prostate needle biopsy or surgery on the detection and harvest of intact circulating prostate cancer cells..” The Journal of Urology 162, no. 3 Pt 1 (September 1999): 749–52. https://doi.org/10.1097/00005392-199909010-00034.
       Full Text
    • Polascik, T. J., J. E. Oesterling, and A. W. Partin. “Prostate specific antigen: a decade of discovery--what we have learned and where we are going..” The Journal of Urology 162, no. 2 (August 1999): 293–306. https://doi.org/10.1016/s0022-5347(05)68543-6.
       Full Text
    • Polascik, T. J., M. J. Manyak, M. K. Haseman, R. T. Gurganus, B. Rogers, R. T. Maguire, and A. W. Partin. “Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients..” Cancer 85, no. 7 (April 1999): 1586–92. https://doi.org/10.1002/(sici)1097-0142(19990401)85:7<1586::aid-cncr21>3.0.co;2-f.
       Full Text
    • Polascik, T. J., U. Hamper, B. R. Lee, Y. Dai, J. Hilton, C. A. Magee, J. K. Crone, et al. “Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology..” Urology 53, no. 3 (March 1999): 465–72. https://doi.org/10.1016/s0090-4295(98)00651-7.
       Full Text
    • Polascik, T. J., A. W. Partin, C. R. Pound, and F. F. Marshall. “Frequent occurrence of metastatic disease in patients with renal cell carcinoma and intrahepatic or supradiaphragmatic intracaval extension treated with surgery: an outcome analysis..” Urology 52, no. 6 (December 1998): 995–99. https://doi.org/10.1016/s0090-4295(98)00367-7.
       Full Text
    • Polascik, T. J., J. D. Pearson, A. W. Partin, and Dr T. J. Polascik. “Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer..” Prostate Cancer and Prostatic Diseases 1, no. 6 (December 1998): 301–6. https://doi.org/10.1038/sj.pcan.4500258.
       Full Text
    • Polascik, T. J., J. D. Pearson, and A. W. Partin. “Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen..” Seminars in Urologic Oncology 16, no. 3 (August 1998): 160–71.
    • Polascik, T. J., and R. N. Chen. “Laparoscopic ureteroureterostomy for retrocaval ureter..” The Journal of Urology 160, no. 1 (July 1998): 121–22. https://doi.org/10.1016/s0022-5347(01)63053-2.
       Full Text
    • Polascik, T. J., C. R. Pound, T. L. DeWeese, and P. C. Walsh. “Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis..” Urology 51, no. 6 (June 1998): 884–89. https://doi.org/10.1016/s0090-4295(98)00153-8.
       Full Text
    • Steiner, G., P. Cairns, T. J. Polascik, F. F. Marshall, J. I. Epstein, D. Sidransky, and M. Schoenberg. “High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2..” Cancer Research 56, no. 21 (November 1996): 5044–46.
    • Polascik, T. J., K. M. Chan-Tack, R. D. Jeffs, and J. P. Gearhart. “Reappraisal of the role of human chorionic gonadotropin in the diagnosis and treatment of the nonpalpable testis: a 10-year experience..” The Journal of Urology 156, no. 2 Pt 2 (August 1996): 804–6. https://doi.org/10.1097/00005392-199608001-00069.
       Full Text
    • Polascik, T. J., P. Cairns, J. I. Epstein, L. Fuzesi, J. Y. Ro, F. F. Marshall, D. Sidransky, and M. Schoenberg. “Distal nephron renal tumors: microsatellite allelotype..” Cancer Research 56, no. 8 (April 1996): 1892–95.
    • Polascik, T. J., M. V. Meng, J. I. Epstein, and F. F. Marshall. “Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients..” The Journal of Urology 154, no. 5 (November 1995): 1676–80. https://doi.org/10.1016/s0022-5347(01)66748-x.
       Full Text
    • Polascik, T. J., P. Cairns, W. Y. Chang, M. P. Schoenberg, and D. Sidransky. “Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma..” Cancer Research 55, no. 22 (November 1995): 5396–99.
    • Cairns, P., T. J. Polascik, Y. Eby, K. Tokino, J. Califano, A. Merlo, L. Mao, et al. “Frequency of homozygous deletion at p16/CDKN2 in primary human tumours..” Nature Genetics 11, no. 2 (October 1995): 210–12. https://doi.org/10.1038/ng1095-210.
       Full Text
    • Polascik, T. J., C. R. Pound, M. V. Meng, A. W. Partin, and F. F. Marshall. “Partial nephrectomy: technique, complications and pathological findings..” The Journal of Urology 154, no. 4 (October 1995): 1312–18. https://doi.org/10.1016/s0022-5347(01)66845-9.
       Full Text
    • Chang, W. Y., P. Cairns, M. P. Schoenberg, T. J. Polascik, and D. Sidransky. “Novel suppressor loci on chromosome 14q in primary bladder cancer..” Cancer Research 55, no. 15 (August 1995): 3246–49.
    • Polascik, T. J., and P. C. Walsh. “Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function..” The Journal of Urology 154, no. 1 (July 1995): 150–52. https://doi.org/10.1097/00005392-199507000-00048.
       Full Text
    • Polascik, T. J., R. G. Moore, M. T. Rosenberg, and L. R. Kavoussi. “Comparison of laparoscopic and open retropubic urethropexy for treatment of stress urinary incontinence..” Urology 45, no. 4 (April 1995): 647–52. https://doi.org/10.1016/s0090-4295(99)80057-0.
       Full Text
    • Riopel, M. A., T. J. Polascik, A. W. Partin, J. Sauvageot, P. C. Walsh, and J. I. Epstein. “Radical prostatectomy in men less than 50 years old..” Urologic Oncology 1, no. 2 (March 1995): 80–83. https://doi.org/10.1016/1078-1439(95)00010-f.
       Full Text
    • Elliott, W. J., T. J. Polascik, and M. B. Murphy. “Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE-inhibitor.” Journal of Human Hypertension 4, no. 6 (December 1990): 717–23.
    • Polascik, T., P. P. Godfrey, and S. P. Watson. “Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets.” Biochemical Journal 243, no. 3 (May 1, 1987): 815–19. https://doi.org/10.1042/bj2430815.
       Full Text

  • Book Sections

    • Tay, K. J., M. Tsivian, and T. J. Polascik. “Prostate cryotherapy.” In Management of Prostate Cancer: A Multidisciplinary Approach, Second Edition, 273–85, 2017. https://doi.org/10.1007/978-3-319-42769-0_18.
       Full Text
    • Mancini, J. G., and T. J. Polascik. “Definitions and principles of focal therapy.” In Technical Aspects of Focal Therapy in Localized Prostate Cancer, 19–28, 2015. https://doi.org/10.1007/978-2-8178-0484-2_3.
       Full Text
    • Rosenzweig, S., Z. Miller, T. Polascik, and K. Nightingale. “Prostate elastography.” In Prostate Ultrasound: Current Practice and Future Directions, 163–72, 2015. https://doi.org/10.1007/978-1-4939-1948-2_12.
       Full Text
    • Mouraviev, V., and T. J. Polascik. “Focal therapy: Prostate hemiablation as the first historical treatment model for focal therapy of early stage prostate cancer.” In Management of Prostate Cancer: Third Edition, 225–41, 2013. https://doi.org/10.1007/978-1-60761-259-9_14.
       Full Text
    • Mouraviev, V., and T. J. Polascik. “Selection criteria for focal therapy of prostate cancer.” In Imaging and Focal Therapy of Early Prostate Cancer, 245–53, 2013. https://doi.org/10.1007/978-1-62703-182-0_18.
       Full Text
    • Polascik, T. J., A. Villers, T. M. Wheeler, D. G. Bostwick, R. Montironi, P. Nevoux, and V. Mouraviev. “Pathologic basis for focal therapy: Understanding cancer grade, volume, and spatial location.” In Imaging and Focal Therapy of Early Prostate Cancer, 53–71, 2013. https://doi.org/10.1007/978-1-62703-182-0_4.
       Full Text
    • Polascik, T. J., and V. Mouraviev. “Roadmap for focal therapy.” In Imaging and Focal Therapy of Early Prostate Cancer, 383–88, 2013. https://doi.org/10.1007/978-1-62703-182-0_28.
       Full Text
    • Tsivian, M., and T. J. Polascik. “Cryotherapy of the Prostate.” In Smith’s Textbook of Endourology: 3rd Edition, 2:1406–15, 2012. https://doi.org/10.1002/9781444345148.ch116.
       Full Text
    • Tsivian, M., and T. J. Polascik. “Cryotherapy.” In Management of Prostate Cancer: A Multidisciplinary Approach, 213–23, 2012. https://doi.org/10.1007/978-3-642-27597-5_16.
       Full Text
    • Mouraviev, V., T. M. Wheeler, and T. J. Polascik. “Histological Trends and the Index Lesion in Localized Prostate Cancer.” In Focal Therapy in Prostate Cancer, 17–28, 2011. https://doi.org/10.1002/9781444346893.ch3.
       Full Text

  • Other Articles

    • Polascik, Thomas J., and Kae Jack Tay. “Editorial Comment..” The Journal of Urology, September 2016. https://doi.org/10.1016/j.juro.2016.02.3001.
       Full Text
    • Polascik, Thomas J., Kae Jack Tay, and Judd W. Moul. “Keeping an Open Mind About Novel Concepts for Management of Prostate Cancer..” European Urology, December 2015. https://doi.org/10.1016/j.eururo.2015.02.024.
       Full Text
    • Polascik, Thomas J. “Focal therapy of prostate cancer: making steady progress toward a first-line image-guided treatment modality..” Current Opinion in Urology, May 2015. https://doi.org/10.1097/mou.0000000000000171.
       Full Text
    • Passoni, Niccolò M., and Thomas J. Polascik. “Words of wisdom. Re: Tracking the clonal origin of lethal prostate cancer..” European Urology, August 2014. https://doi.org/10.1016/j.eururo.2014.05.022.
       Full Text
    • Passoni, Niccolò M., and Thomas J. Polascik. “Targeted prostate biopsies: the complexity behind a simple concept..” European Urology, July 2014. https://doi.org/10.1016/j.eururo.2014.03.025.
       Full Text
    • Tsivian, Matvey, Michael R. Abern, and Thomas J. Polascik. “Prostate cancer treatment unblinded..” The Lancet. Oncology, June 2012. https://doi.org/10.1016/s1470-2045(12)70136-5.
       Full Text
    • Tsivian, Matvey, and Thomas J. Polascik. “Prostate cancer: ideal candidates for focal therapy..” Nature Reviews. Urology, January 2012. https://doi.org/10.1038/nrurol.2011.206.
       Full Text
    • Cotter, S. E., M. H. Chen, J. W. Moul, W. R. Lee, B. F. Koontz, M. S. Anscher, C. N. Robertson, P. J. Walther, T. J. Polascik, and A. V. D’Amico. “Re: Salvage radiation in men after prostate-specific antigen failure and the risk of death.” Journal of Urology, November 1, 2011. https://doi.org/10.1016/j.juro.2011.08.056.
       Full Text
    • Tang, P., L. Sun, M. A. Uhlman, C. N. Robertson, T. J. Polascik, and J. W. Moul. “Re: Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.” Journal of Urology, November 1, 2011. https://doi.org/10.1016/j.juro.2011.07.063.
       Full Text
    • Tsivian, Matvey, and Thomas J. Polascik. “The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy..” Bju International, August 2011. https://doi.org/10.1111/j.1464-410x.2011.10496.x.
       Full Text
    • Tsivian, M., J. Caso, M. Kimura, and T. J. Polascik. “Renal function outcomes after laparoscopic renal cryoablation.” International Braz J Urol, July 1, 2011. https://doi.org/10.1590/S1677-55382011000400016.
       Full Text
    • Matvey, Tsivian, and Thomas J. Polascik. “Editorial comment..” Urology, May 2011. https://doi.org/10.1016/j.urology.2010.12.050.
       Full Text
    • Eggener, Scott, Georg Salomon, Peter T. Scardino, Jean De la Rosette, Thomas J. Polascik, and Simon Brewster. “Corrigendum to "Focal Therapy for Prostate Cancer: Possibilities and Limitations" [Eur Urol 2010;58:57-64]..” European Urology, October 2010. https://doi.org/10.1016/j.eururo.2010.07.001.
       Full Text
    • Tsivian, Matvey, and Thomas J. Polascik. “Editorial comment..” Urology, September 2010. https://doi.org/10.1016/j.urology.2009.12.024.
       Full Text
    • Rosette, Jean de la, Inderbir Gill, and Thomas Polascik. “Focal therapy for prostate and renal cancer--are we ready for it?.” Journal of Endourology, May 2010. https://doi.org/10.1089/end.2010.1504.
       Full Text
    • Megwalu, I. I., G. G. Ferguson, J. T. Wei, V. Mouraviev, T. J. Polascik, S. Taneja, L. Black, G. L. Andriole, and A. S. Kibel. “Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer (BJU International (2008) 102 (546-50).” Bju International, July 1, 2009. https://doi.org/10.1111/j.1464-410X.2009.08755.x.
       Full Text
    • Chen, V. H., J. M. Mayes, V. Mouraviev, T. J. Polascik, and Jeffrey A. Cadeddu. “Urothelial Sloughing With Obstruction After Laparoscopic Cryoablation of Small Renal Carcinoma in Solitary Kidney Editoral Comment.” Journal of Urology, April 2009.
       Link to Item
    • Chin, Joseph L. “Editorial Comment.” Journal of Urology. Ovid Technologies (Wolters Kluwer Health), June 2008. https://doi.org/10.1016/j.juro.2008.01.248.
       Full Text
    • Polascik, T. J. “Editorial Comment.” Journal of Urology, June 1, 2008. https://doi.org/10.1016/j.juro.2008.01.250.
       Full Text
    • Mayes, J. M., V. Mouraviev, L. Sun, J. F. Madden, and T. J. Polascik. “WITHDRAWN: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?.” Prostate Cancer and Prostatic Diseases, May 13, 2008. https://doi.org/10.1038/pcan.2008.31.
       Full Text
    • Polascik, Thomas J., and Vladimir Mouraviev. “The rise of ablative technologies for treating the small renal mass..” European Urology, September 2007. https://doi.org/10.1016/j.eururo.2007.03.005.
       Full Text
    • Mouraviev, V., and T. J. Polascik. “Editorial comment.” Journal of Urology, June 1, 2006. https://doi.org/10.1016/S0022-5347(06)00657-4.
       Full Text
    • Raj, G. V., D. J. Reddan, M. B. Hoey, and T. J. Polascik. “Erratum: Management of Small Renal Tumors with Radiofrequency Ablation (Urology (January 2003) 61 (23-29)).” Urology, July 1, 2004. https://doi.org/10.1016/j.urology.2004.06.002.
       Full Text
    • Zlotta, A. R., and C. C. Schulman. “Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy..” Urology, August 1999.
    • Polascik, T. J., A. W. Partin, C. R. Pound, and F. F. Marshall. “Long-term survival after radical nephrectomy with intrahepatic or supradiaphragmatic intracaval thrombectomy for renal cell carcinoma.” British Journal of Urology, December 1, 1997.
    • Polascik, T. J., C. R. Pound, M. Z. Meng, A. W. Partin, and F. F. Marshall. “Partial nephrectomy: technique, complications and pathologic findings.” British Journal of Urology, December 1, 1997.

  • Conference Papers

    • Chan, D. Y., S. L. Lipman, M. L. Palmeri, D. C. Morris, T. J. Polascik, N. C. Rouze, and K. R. Nightingale. “Prostate Shear Wave Elastography: Multiresolution Reconstruction Dependence on Push Beam Spacing.” In Ieee International Ultrasonics Symposium, Ius, Vol. 2018-January, 2018. https://doi.org/10.1109/ULTSYM.2018.8580076.
       Full Text
    • Cody Morris, D., D. Y. Chan, M. L. Palmeri, T. J. Glass, M. M. McCormick, K. Jack Tay, T. J. Polascik, R. T. Gupta, and K. R. Nightingale. “Correlation Between 3D ARFI and Quantitative Imaging Metrics from SWEI and Multi-Parametric MRI in Vivo in Normal and Cancerous Prostate Tissue.” In Ieee International Ultrasonics Symposium, Ius, Vol. 2018-January, 2018. https://doi.org/10.1109/ULTSYM.2018.8579729.
       Full Text
    • Palmeri, M., T. Glass, R. Gupta, M. McCormick, A. Brown, T. Polascik, S. Rosenzweig, A. Buck, and K. Nightingale. “Comparison between 3D ARFI imaging and mpMRI in detecting clinically-significant prostate cancer lesions.” In Ieee International Ultrasonics Symposium, Ius, Vol. 2016-November, 2016. https://doi.org/10.1109/ULTSYM.2016.7728618.
       Full Text
    • Miller, Z. A., M. L. Palmeri, S. J. Rosenzweig, T. J. Glass, K. R. Nightingale, T. J. Polascik, A. Buck, and J. Madden. “3D in vivo ARFI imaging: Prostate cancer sensitivity.” In Ieee International Ultrasonics Symposium, Ius, 209–12, 2014. https://doi.org/10.1109/ULTSYM.2014.0053.
       Full Text
    • Rosenzweig, S., N. Rouze, B. Byram, M. Palmeri, T. Polascik, and K. Nightingale. “Bayesian shear wave speed estimation for in vivo 3D imaging of the prostate.” In Ieee International Ultrasonics Symposium, Ius, 1260–63, 2013. https://doi.org/10.1109/ULTSYM.2013.0322.
       Full Text
    • Rosenzweig, S., M. Palmeri, N. Rouze, S. Lipman, E. Kulbacki, J. Madden, T. Polascik, and K. Nightingale. “Comparison of concurrently acquired in vivo 3D ARFI and SWEI images of the prostate.” In Ieee International Ultrasonics Symposium, Ius, 97–100, 2012. https://doi.org/10.1109/ULTSYM.2012.0024.
       Full Text
    • Hsu, C. M. L., T. J. Polascik, M. S. Davenport, C. Kauffman, R. T. Gupta, E. Kulbacki, J. Madden, S. L. Lipman, M. L. Palmeri, and K. R. Nightingale. “Methodology to register prostate B-mode and ARFI images to MR and histology.” In Ieee International Ultrasonics Symposium, Ius, 1866–69, 2011. https://doi.org/10.1109/ULTSYM.2011.0466.
       Full Text
    • Koontz, B. F., L. Gerber, L. L. Bañez, I. T. Degirmenci, Z. Vujaskovic, M. S. Anscher, C. N. Robertson, T. J. Polascik, J. W. Moul, and W. R. Lee. “3D Conformal and Intensity Modulated Radiotherapy to the Prostate Bed have Similar Biochemical Outcomes.” In International Journal of Radiation Oncology*Biology*Physics, 81:S406–7. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.659.
       Full Text
    • Koontz, B. F., W. R. Lee, Z. Vujaskovic, M. Carroll, B. P. Quaranta, M. S. Anscher, C. N. Robertson, T. J. Polascik, and J. W. Moul. “Neoadjuvant Radiotherapy plus Prostatectomy for High Risk Prostate Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 81:S397–S397. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.640.
       Full Text
    • Wattson, D. A., M. Chen, J. W. Moul, B. J. Moran, D. E. Dosoretz, C. N. Robertson, T. J. Polascik, M. H. Braccioforte, S. A. Salenius, and A. V. D’Amico. “The Number of High-Risk Factors and the Risk of Prostate Cancer-Specific Mortality Following Radical Prostatectomy or Brachytherapy.” In International Journal of Radiation Oncology*Biology*Physics, 81:S434–S434. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.716.
       Full Text
    • Calloway, Elizabeth E., David I. Chu, Leah Gerber, Jean-Alfred Thomas, Cary N. Robertson, Thomas J. Polascik, Judd W. Moul, and Lionel L. Bañez. “1204 HEIGHT AND THE RISK FOR AGGRESSIVE PROSTATE CANCER AT THE TIME OF BIOPSY–RESULTS FROM THE DUKE PROSTATE CENTER DATABASE.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.839.
       Full Text
    • Gerber, Leah, Lionel L. Bãnez, Stephen J. Freedland, Donghua Xie, Jim J. Qi, Thomas J. Polascik, Cary N. Robertson, and Judd W. Moul. “335 DIABETES MELLITUS AND THE RISK OF HIGH-GRADE PROSTATE CANCER: RESULTS FROM THE DUKE PROSTATE CENTER.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.419.
       Full Text
    • Kimura, M., M. Tsivian, J. Caso, D. M. Moreira, V. Mouraviev, C. F. Donatucci, and T. J. Polascik. “ON-DEMAND USE OF ERECTILE AIDS IN MEN WITH SEVERE PREOPERATIVE ERECTILE FUNCTION TREATED BY PROSTATE CRYOABLATION.” In Journal of Sexual Medicine, 8:37–37, 2011.
       Link to Item
    • Kimura, M., B. F. Koontz, H. Yan, Z. Rabbani, T. Satoh, S. Baba, F. Yin, C. F. Donatucci, T. J. Polascik, and Z. Vujaskovic. “A Modern Animal Model of Radiation-induced Erectile Dysfunction.” In International Journal of Radiation Oncology*Biology*Physics, 78:S40–S40. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.130.
       Full Text
    • Tsivian, M., C. Y. Kim, J. R. Caso, M. Rosenberg, V. Mouraviev, D. M. Albala, R. Nelson, and T. J. Polascik. “CONTRAST ENHANCEMENT AFTER RENAL CRYOABLATION: AN EVIDENCE OF TREATMENT FAILURE?.” In Journal of Endourology, 24:A236–37. MARY ANN LIEBERT INC, 2010.
       Link to Item
    • Tsivian, M., J. R. Caso, M. Kimura, J. F. Madden, T. J. Polascik, and V. Mouraviev. “A NOVEL CO2-LASER PARTIAL NEPHRECTOMY: PILOT STUDY IN A PORCINE MODEL.” In Journal of Endourology, 24:A13–A13. MARY ANN LIEBERT INC, 2010.
       Link to Item
    • Zhai, L., J. Madden, V. Mouraviev, T. Polascik, and K. Nightingale. “Correlation between SWEI and ARFI image findings in ex vivo human prostates.” In Proceedings  Ieee Ultrasonics Symposium, 2009. https://doi.org/10.1109/ULTSYM.2009.5441796.
       Full Text
    • Koontz, Bridget F., Brian P. Quaranta, Madelaine Carroll, Zeljko Vujaskovic, W Robert Lee, Cary N. Robertson, Thomas J. Polascik, Mitchell S. Anscher, and Judd W. Moul. “PHASE I TRIAL OF PROSTATECTOMY AFTER PLANNED PRE-OPERATIVE RADIOTHERAPY FOR HIGH RISK LOCALIZED PROSTATE CANCER: PRELIMINARY RESULTS.” In The Journal of Urology, 181:713–713. Ovid Technologies (Wolters Kluwer Health), 2009. https://doi.org/10.1016/s0022-5347(09)61992-3.
       Full Text
    • Shingleton, B., B. Wynia, J. Mayes, M. Tsivian, V. Mouraviev, and T. J. Polascik. “323 LAPAROSCOPIC AND PERCUTANEOUS CRYO ABLATION FOR RENAL TUMORS: A TWO-INSTITUTION EXPERIENCE.” In European Urology Supplements, 8:201–201. Elsevier BV, 2009. https://doi.org/10.1016/s1569-9056(09)60327-4.
       Full Text
    • Zhai, L., J. Dahl, J. Madden, V. Mouraviev, T. Polascik, M. Palmeri, and K. Nightingale. “Three-dimensional acoustic radiation force impulse (ARFI) imaging of human prostates in vivo.” In Proceedings  Ieee Ultrasonics Symposium, 540–43, 2008. https://doi.org/10.ll09/ULTSYM.2008.0131.
       Full Text
    • Moul, Judd W., Leon Sun, Cary N. Robertson, Craig F. Donatucci, David M. Albala, Phillip J. Walther, Vladimir Mouraviev, Florian R. Schroeck, and Thomas J. Polascik. “OLDER MEN ASSOCIATED WITH ADVANCED DISEASE AND POOR OUTCOME: AN ANALYSIS OF 14601 PROSTATE CANCER MEN IN DUKE PROSTATE CENTER.” In Journal of Urology, 179:641–641. Ovid Technologies (Wolters Kluwer Health), 2008. https://doi.org/10.1016/s0022-5347(08)61875-3.
       Full Text
    • Mouraviev, Vladimir, Janice M. Mayes, Laurean Jackson, Alexandra J. Stein, Timothy Haystead, Zeljko Vujaskovic, and Thomas J. Polascik. “NEOADJUVANT DOCETAXEL WITH SUBSEQUENT CYOABLATION OF AN AGGRESSIVE RM-9 MURINE PROSTATE CANCER MODEL IS ASSOCIATED WITH DECREASE IN INTERSTITIAL FLUID PRESSURE AND IMPROVEMENT OF OXYGENATION.” In Journal of Urology, 179:420–420. Ovid Technologies (Wolters Kluwer Health), 2008. https://doi.org/10.1016/s0022-5347(08)61231-8.
       Full Text
    • Sun, Leon, Kevin C. Zorn, David M. Albala, Sergey A. Shikanov, Gregory P. Zagaja, Arieh L. Shalhav, Cary N. Robertson, et al. “PRE-TREATMENT FACTORS PREDICTIVE OF POSITIVE SURGICAL MARGIN IN CONTEMPORARY RADICAL PROSTATECTOMIES.” In Journal of Urology, 179:250–250. Ovid Technologies (Wolters Kluwer Health), 2008. https://doi.org/10.1016/s0022-5347(08)60724-7.
       Full Text
    • Zhai, L., J. Madden, V. Mouraviev, T. Polascik, and K. Nightingale. “Visualizing the anatomic structures of human prostates using Acoustic Radiation Force Impulse (ARFI) imaging.” In Proceedings  Ieee Ultrasonics Symposium, 432–35, 2007. https://doi.org/10.1109/ULTSYM.2007.117.
       Full Text
    • Mayes, Janice M., Vladimir Mouraviev, Israel Nosnik, and Thomas J. Polascik. “The complication rate after cryosurgical ablation for clinically localized prostate cancer using third generation cryotechnology.” In Journal of Endourology, 21:A148–49, 2007.
       Link to Item
    • Mouraviev, Vladimir, Janice M. Mayes, Israel Nosnik, and Thomas J. Polascik. “Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third generation cryotechnology.” In Journal of Endourology, 21:A149–A149, 2007.
       Link to Item
    • Mouraviev, Vladimir, Leon Sun, John F. Madden, Janice M. Mayes, Judd W. Moul, Daniel J. George, Philip G. Febbo, and Thomas J. Polascik. “Tumor laterality does not predict biochemical prostate cancer recurrence after radical prostatectomy.” In Journal of Endourology, 21:A216–A216. MARY ANN LIEBERT INC, 2007.
       Link to Item
    • Polascik, Thomas J., Israel Nosnik, Janice M. Mayes, and Vladimir Mouraviev. “Financial comparative analysis of minimally invasive surgery to open surgery for small renal tumors less than 3.5 cm: A single institutional experience.” In Journal of Endourology, 21:A115–A115, 2007.
       Link to Item
    • Polascik, Thomas J., Leon Sun, John F. Madden, Janice M. Mayes, Daniel J. George, Philip G. Febbo, and Vladimir Mouraviev. “Prostate cancer laterality as a rationale for the clinical application of focal ablative therapy: An analysis of 1184 prostatectomy specimens.” In Journal of Endourology, 21:A216–A216. MARY ANN LIEBERT INC, 2007.
       Link to Item
    • Polascik, T. J., V. Mouraviev, and I. Nosnik. “Laparoscopic renal cryoablation for tumors less than 3.5 cm.” In Journal of Endourology, 20:A177–A177, 2006.
       Link to Item
    • Proia, A. D., L. L. Sun, K. R. Perkinson, T. J. Polascik, V. Mouraviev, C. F. Donatucci, C. N. Robertson, et al. “Ki-67: A potential prognostic biomarker for PSA recurrence?.” In Journal of Urology, 175:87–87. LIPPINCOTT WILLIAMS & WILKINS, 2006.
       Link to Item
    • Brashears, J. H., A. Crisci, R. C. Nelson, and T. J. Polascik. “Renal radiofrequency ablation: Worst case scenarios in a porcine model.” In American Journal of Roentgenology, 182:14–15. AMER ROENTGEN RAY SOC, 2004.
       Link to Item
    • Demark-Wahnefried, W., T. J. Polascik, C. N. Robertson, P. J. Walther, and D. F. Paulson. “Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia..” In Cancer Epidemiology Biomarkers & Prevention, 11:1171S-1171S. AMER ASSOC CANCER RESEARCH, 2002.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.